|
Box | Folder
|
Title
|
| |
Research Data PET Scans,
1953-2002, undated [subseries]:
|
| |
Numbered,
1981, undated [subseries]:
|
| 50 |
1 |
1 autoradiograph with standard [photographs, negative],
undated
|
| 50 |
2 |
2 DG + DG2 + MG molecules [photographs, negative],
undated
|
| 50 |
3 |
3 DG through brain barrier [photographs, negative],
undated
|
| 50 |
4 |
4 functional anatomy of operational -- *DG equ. [photographs, negative],
undated
|
| 50 |
5 |
5 lumped constant in several species [photographs, negative],
undated
|
| 50 |
6 |
6 glucose utilization in conscious rat and monkey [photographs, negative],
undated
|
| 50 |
7 |
7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative],
undated
|
| 50 |
8 |
8 spinal cord effects of unilateral stimulation [photographs, negative],
undated
|
| 50 |
9 |
9 relationship between frequency of stimulation and LGU [photographs, negatives, slides],
undated
|
| 50 |
10 |
10 focal seizure during LGU [photographs, negatives],
undated
|
| 50 |
11 |
11 otitis [photographs, negatives],
undated
|
| 50 |
12 |
12 left eye removed (rat) L.G.U. [photographs, negatives],
undated
|
| 50 |
13 |
13 coronal brain (monkey) [photographs, negatives],
undated
|
| 50 |
14 |
14 coronal brain (monkey) -- rt. eye occluded,
undated
|
| 50 |
15 |
15 [negative],
undated
|
| 50 |
16 |
16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative],
undated
|
| 50 |
17 |
17 apomorphine rt. eye enucleated [photographs, negative],
undated
|
| 50 |
18 |
18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative],
undated
|
| 50 |
19 |
19 computer diagram image display system [photographs, negative],
undated
|
| 50 |
20 |
20 average brain cerebral glucose utilization [negative],
undated
|
| 50 |
21 |
21 ageing and metabolism [photographs, negative],
undated
|
| 50 |
22 |
22 ageing and metabolism [photographs, negative],
undated
|
| 50 |
23 |
23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative],
undated
|
| 50 |
24 |
24 ageing, LCGU vs. apomorphine [photographs, negative],
undated
|
| 50 |
25 |
25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative],
undated
|
| 50 |
26 |
26 LCGU vs. apomorphine (ageing) [photographs, negative],
undated
|
| 50 |
27 |
27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative],
undated
|
| 50 |
28 |
28 glucose metabolic rate (FDG) [photographs, negative],
undated
|
| 50 |
29 |
29 LCGU vs. apomorphine (age),
undated
|
| 50 |
30 |
30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative],
undated
|
| 50 |
31 |
31 LCBF indicator fraction method [photographs, negative],
undated
|
| 50 |
32 |
32 spreading depression [photographs, negative],
undated
|
| 50 |
33 |
33 [photographs, negative],
undated
|
| 50 |
34 |
34 electrical stimulation and DG* uptake in pituitary [negative],
undated
|
| 50 |
35 |
35 socium pump and neurosecretion effects on DG* uptake [photographs, negative],
undated
|
| 50 |
36 |
36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative],
undated
|
| 50 |
37 |
37 radioactivity DPM vs. time curves [photographs, negative],
undated
|
| 50 |
38 |
38 spreading cortical depression (KCI) [photographs, negative],
1981
|
| 50 |
39 |
39 osmotic opening of BBB [photographs, negative],
undated
|
| 50 |
40 |
40 blood flow vs. LGU in conscious and anesthetized [photographs, negative],
undated
|
| 50 |
41 |
41 [photographs, negative],
undated
|
| 50 |
42 |
42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative],
undated
|
| 50 |
43 |
43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative],
undated
|
| 50 |
44 |
44 effects of light intensity on LGU [photographs, negative],
undated
|
| 50 |
45 |
45 [125I] hipdm single pass extraction vs. venous [photographs, negative],
undated
|
| 50 |
46 |
46 deosyglucose vs. glucose in arterial and venous [photographs, negative],
undated
|
| 50 |
47-48 |
47 influence of rate constants on integrated pool specific activity [photographs, negative],
undated
|
| 50 |
49 |
48 rate constants in the normal conscious albino rat [negative],
undated
|
| 50 |
50 |
49 lump constant vs. time [photographs, negative],
undated
|
| 50 |
51 |
50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative],
undated
|
| 50 |
52 |
51 blood CO2 curves [photographs, negative],
undated
|
| 50 |
53 |
52 striate cortex (monkey) [photographs, negative],
undated
|
| 50 |
54 |
53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative],
undated
|
| 50 |
55 |
54 LCGU vs. apomorphine [photograph, negative, slides],
undated
|
| 50 |
56 |
55 systems involved in higher functions [negative],
undated
|
| 50 |
57 |
56 auditory system (LCGU) [negative],
undated
|
| 50 |
58 |
57 auxtomy, leucine protein synthesis [photographs, negative],
undated
|
| 50 |
59 |
58 auxtomy, DG, protein synthesis nissl stain [photographs, negative],
undated
|
| 50 |
60 |
59 3H and 24C DG [photographs, negative],
undated
|
| 50 |
61 |
60 brain anatomy labeled [photographs, negative],
undated
|
| 50 |
62 |
61 experimental period effects on gray matter glucose utilization [photographs, negative],
undated
|
| 50 |
63 |
62 visual stimulus (3H] DG [photographs, negative],
undated
|
| 50 |
64 |
63 pretectal nucleus [photographs, negative],
undated
|
| 50 |
65 |
64 visual cortex [photographs, negative],
undated
|
| 50 |
66 |
65 lateral geniculate nucleus [photographs, negative],
undated
|
| 50 |
67 |
66 posterolateral nucleus of the thalamus [photographs, negative],
undated
|
| 50 |
68 |
67 blood flow vs. LCGU (control) [photographs, negative],
undated
|
| 50 |
69 |
68 blood flow vs. LCGU (acidosis) [photographs, negative],
undated
|
| 50 |
70 |
69 blood flow vs. LCGU (acidosis and control) [photographs, negative],
undated
|
| 50 |
71 |
70 antidromic stimulation of superior cervical ganglion [photographs, negative],
undated
|
| 50 |
72 |
71 superior colliculus LCGU vs. light intensity [photographs, negative],
undated
|
| 50 |
73 |
72 *DG and *DG-6-phosphate concentration over time [photographs, negative],
undated
|
| 50 |
74 |
73 antidomic stimulation of superior cervical ganglion [photographs, negative],
undated
|
| 50 |
75 |
74 antidromic stimulation of superior cervical ganglion [photographs, negative],
undated
|
| 50 |
76 |
75 air embolism and control in K+ concentration [photographs, negative],
undated
|
| 50 |
77 |
76 air embolism and control in pH of injection fluid [photographs, negative],
undated
|
| 50 |
78 |
78 post axotomy and control [photographs, negative],
undated
|
| 50 |
79 |
80 [photographs, negative],
undated
|
| 50 |
80 |
81 hypoxemia [photographs, negative],
undated
|
| 50 |
81 |
82 darkness vs. 700 lux (pigmented rats) [photographs, negative],
undated
|
| 50 |
82 |
83 hypoxemia [photographs, negative],
undated
|
| 50 |
83 |
84 hypoxemia [photographs, negative],
undated
|
| 50 |
84 |
85 darkness vs. 700 lux (albino rats) [photographs, negative],
undated
|
| 50 |
85 |
86 newborn monkey [photographs, negative],
undated
|
| 50 |
86 |
87 [photographs, negative],
undated
|
| 50 |
87 |
88 spinal cord [photographs, negative],
undated
|
| 50 |
88 |
89 globus pallidus, etc. [negative],
undated
|
| 50 |
89 |
90 reginal glucose utilization [photographs, negative],
undated
|
| 50 |
90 |
91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative],
undated
|
| 50 |
91 |
92 [photograph],
undated
|
| 50 |
92 |
93 left eye removed [photographs, negative],
undated
|
| 50 |
93 |
94 penn. seizure antipyrine, baby monkey [photographs, negative],
undated
|
| 50 |
94 |
95 effects of thiopental anesthesia on cerebral glucose utilization [photograph],
undated
|
| 50 |
95 |
97 equilibration of glucose specific activity between plasma and brain [photographs, negative],
undated
|
| 50 |
96 |
98 influence of duration on glucose utilization [photographs, negative],
undated
|
| 50 |
97 |
99 relationship between stimulation and L.G.U. [photographs, negative],
undated
|
| 50 |
98 |
100 determination of glucose specific activity [photographs, negative],
undated
|
| 50 |
99 |
101 brain-plasma glucose equilibration,
undated
|
| 50 |
100 |
102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative],
undated
|
| 50 |
101 |
103 glucose activity in plasma, tissue [negative],
undated
|
| 50 |
102 |
104 cerebral 02 consumption in cerebral blood flow [photographs, negative],
undated
|
| 50 |
103 |
105 half-lives of DG*-6-P in grey and white matter [photographs, negative],
undated
|
| 50 |
104 |
106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative],
undated
|
| 50 |
105 |
107 derivation of operational method for measurement of LCGU [photographs, negative],
undated
|
| 50 |
106 |
108 tissue pool 1/2 life [photographs, negative],
undated
|
| 50 |
107 |
109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative],
undated
|
| 50 |
108 |
110 theoretical calculation of [14c] DG-6-P in rat brain [photographs],
undated
|
| 50 |
109 |
111 general equation + influence of phosphotase activity [photograph, negative],
undated
|
| 50 |
110 |
112 lumped constant calculation used by Hawkins and Miller [photographs],
undated
|
| 50 |
111 |
113 [photograph],
undated
|
| 50 |
112 |
114 equation for changing plasma glucose concentration [photograph, negative],
undated
|
| 50 |
113 |
115 BBB model and equation of 14C glucose uptake [photograph, negative],
undated
|
| 50 |
114 |
116 glucose uptake model + equation [photographs, negative],
undated
|
| 50 |
115 |
117 LCGU in conscious albino and pigmented rats [negative],
undated
|
| 50 |
116 |
118 glucose utilization in sensorimotor systems [negative],
undated
|
| 50 |
117 |
119 glucose utilization in myelinated fiber tracts [negative],
undated
|
| 50 |
118 |
120 glucose utilization in limbic system [negative],
undated
|
| 50 |
119 |
121 glucose utilization in conscious and restrained rats [negative],
undated
|
| 50 |
120 |
122 glucose utilization of the visual system [negative],
undated
|
| 50 |
121 |
123 1/2 life of tissue pool in male rats [negative],
undated
|
| 50 |
122 |
124 turnover of tissue glucose pool in male rats [negative],
undated
|
| 50 |
123 |
125 values of rate constants in normal conscious albino rats [photographs, negative],
undated
|
| 50 |
124 |
127 conditions w/altered function in CNS w/out change in average body metabolism [photograph],
undated
|
| 50 |
125 |
128 relationship between consciousness and cerebral metabolic rate [photograph],
undated
|
| 50 |
126 |
129 sodium pump and neurosecretion effects on DG* uptake,
undated
|
| 50 |
127 |
130 functional anatomy of the DG*method equ. [photographs, negative, slide],
undated
|
| 50 |
128 |
131 operational equation of [14C] DG method [photographs, negatives],
undated
|
| 50 |
129 |
132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives],
undated
|
| 50 |
130 |
135 LCBF with hipdm indicator fractionation method [photographs, negatives],
undated
|
| 50 |
131 |
136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives],
undated
|
| 50 |
132 |
137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives],
undated
|
| 50 |
133 |
138 retinal stimulation in rats [photographs, negatives],
undated
|
| 50 |
134 |
139 local cerebral glucose utilization [photographs, negatives],
undated
|
| 50 |
135 |
140 local cerebral blood flow [photographs, negatives],
undated
|
| 50 |
136 |
141 kinetics of competitive substrate reactions [photographs, negatives],
undated
|
| 50 |
137 |
142 CBF and CMR 02 vs. years [photographs, negatives],
undated
|
| 50 |
138 |
143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives],
undated
|
| 50 |
139 |
144 monkey [photographs, negatives],
undated
|
| 50 |
140 |
145 glucose utilization vs. stimulation frequency [photographs, negatives],
undated
|
| 50 |
141 |
146 operational equation of [14C] deoxyglucose method [photograph],
undated
|
| 50 |
142 |
147 cervical ganglion drawing [photographs, negatives],
undated
|
| 51 |
1 |
148 cervical ganglion drawing [photographs, negatives],
undated
|
| 51 |
2 |
149 cervical ganglion (micro) [photographs, negatives],
undated
|
| 51 |
3 |
150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives],
undated
|
| 51 |
4 |
151 LCGU vs. halperidol [photographs, negatives],
undated
|
| 51 |
5 |
152 LCGU vs. apomorphine [photographs, negatives],
undated
|
| 51 |
6 |
153 preanglionic holinergic fibers [photographs, negatives],
undated
|
| 51 |
7 |
154 pre-ganglionic cholinergic [photographs, negatives],
undated
|
| 51 |
8 |
155 focal seizures -- protein synthesis [photographs, negatives],
undated
|
| 51 |
9 |
156 focal seizures (metabolic effects) [photographs, negatives],
undated
|
| 51 |
10 |
157 optical density, apomorphine vs. halperidol [photographs, negatives],
undated
|
| 51 |
11 |
158 apomorphine vs. haloperidol (magnification) [photographs, negatives],
undated
|
| 51 |
12 |
159 slide to side differences in monkey brain structures [photographs, negatives],
undated
|
| 51 |
13 |
160 LGU in monkey brain [photographs, negatives],
undated
|
| 51 |
14 |
161 influence of age on responsiveness to apomorphine [photographs, negatives],
undated
|
| 51 |
15 |
162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives],
undated
|
| 51 |
16 |
163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives],
undated
|
| 51 |
17 |
164 cervical ganglion [photographs, negatives],
undated
|
| 51 |
18 |
165 regional glucose utilization [photographs, negatives],
undated
|
| 51 |
19 |
166 regional glucose utilization (ketamine) [photographs, negatives],
undated
|
| 51 |
20 |
167 regional glucose utilization (limbic system) [photographs, negatives],
undated
|
| 51 |
21 |
168 regional glucose utilization: auditory, visual, sensory [photographs, negatives],
undated
|
| 51 |
22 |
169 physiologic pearmeters [photographs, negatives],
undated
|
| 51 |
23 |
170 LCGU (percentage change from control) [photographs, negatives],
undated
|
| 51 |
24 |
171 LCGU (percentage change from control) ketamine [photographs, negatives],
undated
|
| 51 |
25 |
172 blood flow transport and metabolism [photographs, negatives],
undated
|
| 51 |
26 |
173 SSA vs. 1/[GHB] [photographs, negatives],
undated
|
| 51 |
27 |
174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives],
undated
|
| 51 |
28 |
175 SSA or NADPH vs. time [photographs, negatives],
undated
|
| 51 |
29 |
176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives],
undated
|
| 51 |
30 |
177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives],
undated
|
| 51 |
31 |
178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives],
undated
|
| 51 |
32 |
179 apomorphine substantia nigra young vs. aged rats [photographs, negatives],
undated
|
| 51 |
33 |
180 monocular deprivation (neonatal monkey) [photographs, negatives],
undated
|
| 51 |
34 |
181 naftidro furyl [photographs, negatives],
undated
|
| 51 |
35 |
182 hypoxemia metabolic raes [photographs, negatives],
undated
|
| 51 |
36 |
183 lateral genic (monkey) [photographs, negatives],
undated
|
| 51 |
37 |
184 ketamine [photographs, negatives],
undated
|
| 51 |
38 |
185 norepinephrine vs. LCGU [photographs, negatives],
undated
|
| 51 |
39 |
186 norepinephrine vs. control LCGU [photographs, negatives],
undated
|
| 51 |
40 |
187 LCGU in white matter during hypoxemia [photographs, negatives],
undated
|
| 51 |
41 |
188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives],
undated
|
| 51 |
42 |
189 lumped constant vs. plasma glucose [photographs, negatives],
undated
|
| 51 |
43 |
190 superior cervical ganglia/glucose utilization [photographs, negatives],
undated
|
| 51 |
44 |
191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives],
undated
|
| 51 |
45 |
192 hexokinase synthesis chart [photographs, negatives],
undated
|
| 51 |
46 |
193 physiological variables in hypoxemia [photographs, negatives],
undated
|
| 51 |
47 |
194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives],
undated
|
| 51 |
48 |
195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives],
undated
|
| 51 |
49 |
196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives],
undated
|
| 51 |
50 |
197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives],
undated
|
| 51 |
51 |
198 hyperglycemia lumped constant [photographs, negatives],
undated
|
| 51 |
52 |
199 time course of arterial and venous concentrations of DG* and G [photographs, negatives],
undated
|
| 51 |
53 |
200 model for behavior of leucine in brain [photographs, negatives],
undated
|
| 51 |
54 |
201 glucose clamp [photographs, negatives],
undated
|
| 51 |
55 |
202 lumped constant at different plasma glucose levels,
undated
|
| 51 |
56 |
203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives],
undated
|
| 51 |
57 |
204 metabolic rates during hypoxemia [photographs, negatives],
undated
|
| 51 |
58 |
205 axotomy hypoglossal nucleus [photographs, negatives],
undated
|
| 51 |
59 |
206 derivation of operational equ.-model I [photographs, negatives],
undated
|
| 51 |
60 |
207 behavior of leucine in brain model [photographs, negatives],
undated
|
| 51 |
61 |
208 differential equations leucine [photographs, negatives],
undated
|
| 51 |
62 |
209 behavior of leucine in brain model 2 [photographs, negatives],
undated
|
| 51 |
63 |
210 differential equations leucine II [photographs, negatives],
undated
|
| 51 |
64 |
211 derivation of operational equ. -- model III [photographs, negatives],
undated
|
| 51 |
65 |
212 leucine brain -- model III [photographs, negatives],
undated
|
| 51 |
66 |
213 differential equations model III [photographs, negatives],
undated
|
| 51 |
67 |
214 derivation of operational equ. model III [photographs, negatives],
undated
|
| 51 |
68 |
215 derivation of operational equ. III continued [photographs, negatives],
undated
|
| 51 |
69 |
216 derivation of equation [photographs, negatives],
undated
|
| 51 |
70 |
217 model IV -- amino acid incorporation into protein [photographs, negatives],
undated
|
| 51 |
71 |
218 derivation of operational equ. model IV [photographs, negatives],
undated
|
| 51 |
72 |
219 derivation of operational equ. -- model IV continued [photographs, negatives],
undated
|
| 51 |
73 |
220 lumped constant in hypoglycemia [photographs, negatives],
undated
|
| 51 |
74 |
221 DG model -- intracellular and extracellular spaces [photographs, negatives],
undated
|
| 51 |
75 |
222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives],
undated
|
| 51 |
76 |
224 physiological variables during insulin-induced hypoglycemia [photographs, negatives],
undated
|
| 51 |
77 |
225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives],
undated
|
| 51 |
78 |
226 synthesis and catabolism of histamine,
undated
|
| 51 |
79 |
227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives],
undated
|
| 51 |
80 |
228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative],
undated
|
| 51 |
81 |
229 superior cervical ganglia (G.U. vs. time) [photographs, negative],
undated
|
| 51 |
82 |
230 synaptic mechanisms for histamine neurons [photographs, negative],
undated
|
| 51 |
83 |
231 visual cortex of monkey [photographs],
undated
|
| 51 |
84 |
232 fetal sheep [photographs, negative],
undated
|
| 51 |
85 |
233 fetal sheep? [photographs, negative],
undated
|
| 51 |
86 |
234 saphenous nerve stimulation during anesthesia [photographs, negative],
undated
|
| 51 |
87 |
235 monkey columns [photographs, negative],
undated
|
| 51 |
88 |
236 norepinephrine vs. control LCGU [photographs, negative],
undated
|
| 51 |
89 |
237 autradiographic resolutions [photographs, negative],
undated
|
| 51 |
90 |
239 layer thickness 3H activity [photographs, negative],
undated
|
| 51 |
91 |
240 LandR hemisphere [photographs, negative],
undated
|
| 51 |
92 |
241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative],
undated
|
| 51 |
93 |
242 [photographs, negative],
undated
|
| 51 |
94 |
243 [photographs, negative],
undated
|
| 51 |
95 |
244 [photographs, negative],
undated
|
| 51 |
96 |
245 olfactory bulbs [photographs, negative],
undated
|
| 51 |
97 |
246 relative optical density [photographs, negative],
undated
|
| 51 |
98 |
247 hot hole plug [photographs, negative],
undated
|
| 51 |
99 |
248 brain standards 3H and 14c [photographs, negative],
undated
|
| 51 |
100 |
249 goldfish retinas [photographs, negative],
undated
|
| 51 |
101 |
250 somata cells labeled and unlabeled [photographs, negative],
undated
|
| 51 |
102 |
251 cat muscle, 24c DG [photographs, negative],
undated
|
| 51 |
103 |
252 3H DG water solution frozen in plasma [photographs, negative],
undated
|
| 51 |
104 |
253 grain density in buccal ganglion [photographs, negative],
undated
|
| 51 |
105 |
254 olfactory bulb in tiger salamander 3HDG [photographs, negative],
undated
|
| 51 |
106 |
255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative],
undated
|
| 51 |
107 |
256 relationship of aggression to onset of lidocaine seizures [photographs, negative],
undated
|
| 51 |
108 |
257 autoradiographic calibration curves vs 3H concentration [photographs, negative],
undated
|
| 51 |
109 |
258 [photographs, negative],
undated
|
| 51 |
110 |
259 occular dominance newborn [photographs, negative],
undated
|
| 51 |
111 |
260 position-emitting atom [photographs, negative],
undated
|
| 51 |
112 |
261 [14C] and [3H] methylglucose [photographs, negative],
undated
|
| 51 |
113 |
262 mid and posterior hypothalamus [photographs, negative],
undated
|
| 51 |
114 |
263 anterior hypothalamus [photographs, negative],
undated
|
| 51 |
115 |
264 dopamine pathways [photographs, negative],
undated
|
| 51 |
116 |
265 integrated tissue specific activity [photographs, negative],
undated
|
| 51 |
117 |
266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative],
undated
|
| 51 |
118 |
267 integrated tissue sp. ac. [photographs, negative],
undated
|
| 51 |
119 |
268 integrated tissue sp. ac. [photographs, negative],
undated
|
| 51 |
120 |
269 integrated tissue sp. ac. [photographs, negative],
undated
|
| 51 |
121 |
270 GHB-dehydrogenase [photographs, negative],
undated
|
| 51 |
122 |
271 GHB-dehydrogenase [photographs, negative],
undated
|
| 51 |
123 |
272 GHB-dehydrogenase [photographs, negative],
undated
|
| 51 |
124 |
273 GHB-dehydrogenase [photographs, negative],
undated
|
| 51 |
125 |
274 GHB-dehydrogenase [photographs, negative],
undated
|
| 51 |
126 |
275 ESN and WFN, Italy (Smith) [negatives],
undated
|
| 51 |
127 |
276 columns in striate cortex (monkey) [photographs, negatives],
undated
|
| 51 |
128 |
278 computer -- block diagram,
undated
|
| 51 |
129 |
279 hypoxic rat injected with black microspheres,
undated
|
| 51 |
130 |
280 dopaminerglic systems influence [photographs, negative],
undated
|
| 51 |
131 |
281 apomorphine vs. saline on LGU [photographs, negative],
undated
|
| 51 |
132 |
282 ocular dominance columns in monkey [photographs, negative],
undated
|
| 51 |
133 |
283 effects of slow-wave sleep on LGU [photographs, negative],
undated
|
| 51 |
134 |
284 subfornical organ in Battleboro [photographs, negative],
undated
|
| 51 |
135 |
285 neural lobe LGU [photographs, negative],
undated
|
| 51 |
136 |
286 two compartment model for the behavior of leucine brain -- model V [photographs, negative],
undated
|
| 51 |
137 |
287 model VI for behavior of L-leucine in brain [photographs, negative],
undated
|
| 51 |
138 |
288 GHB and GABA levels in rat brain [photographs, negative],
undated
|
| 51 |
139 |
289 cytosol -- rat [photographs, negative],
undated
|
| 51 |
140 |
290 GHB levels -- rat kidney [photographs, negative],
undated
|
| 51 |
141 |
291 GHB dehydrogenase activity in rat kidney [photographs, negative],
undated
|
| 51 |
142 |
292 GHB -- dehydrogenase activity in rat brain [photographs, negative],
undated
|
| 51 |
143 |
293 apomorphine effect on different areas [photographs, negative],
undated
|
| 51 |
144 |
294 superior cervical ganglion -- frequency [photographs, negative],
undated
|
| 51 |
145 |
295 lump constant theoretical derivations [photographs, negative],
undated
|
| 51 |
146 |
296 comparison -- LGU with 3H DG and 14C DG [photographs, negative],
undated
|
| 51 |
147 |
298 bar test after morphine [photographs, negative],
undated
|
| 51 |
148 |
299 morphine effect on LGU in brain [photographs, negative],
undated
|
| 51 |
149 |
300 morphine effect on LGU in brain [photographs, negative],
undated
|
| 51 |
150 |
301 fetal sheep [photographs, negative],
undated
|
| 51 |
151 |
302 fetal sheep [photographs, negative],
undated
|
| 51 |
152 |
303 morphine vs. control tail flick [photographs, negative],
undated
|
| 51 |
153 |
304 average rate of GU for entire brain of fetal and newborn sheep,
undated
|
| 51 |
154 |
305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative],
undated
|
| 51 |
155 |
306 extinction -- Icss [photographs, negative],
undated
|
| 51 |
156 |
307 PCO2 and LCGU relationship [photographs, negative],
undated
|
| 51 |
157 |
308 habenula afferent and efferent pathways [photographs, negative],
undated
|
| 51 |
158 |
309 LGU in laboratory animals [photographs, negative],
undated
|
| 51 |
159 |
310 time course of 14C DG and 14C DG-6-P [photographs, negative],
undated
|
| 51 |
160 |
311 LGU and arterial PCO2 relationship [photographs, negative],
undated
|
| 51 |
161 |
312 habenula and mammillary baby pathways [photographs, negative],
undated
|
| 51 |
162 |
313 lateral habenula and mammillary baby pathways [photographs, negative],
undated
|
| 51 |
163 |
314 [14C] deoxyglucose autoradiographs of cat brains [photographs, negative],
undated
|
| 51 |
164 |
315 effect of acute morphine on GU in rat brain [photographs, negative],
undated
|
| 51 |
165 |
315 effect of acute morphine on GU in rat brain [photographs, negative],
undated
|
| 51 |
166 |
316 fetal sheep [photographs],
undated
|
| 51 |
167 |
317 picture procedure, DG method [photographs, negative],
undated
|
| 51 |
168 |
318 axotomy in hypoglossal nucleus [photographs, negative],
undated
|
| 51 |
169 |
319 axotomy -- tongue functions [photographs, negative],
undated
|
| 51 |
170 |
320 age-blood flow and 02 consumption [photographs, negative],
undated
|
| 51 |
171 |
321 exchange of methylglucose between plasma and brain tissue [photographs, negative],
undated
|
| 51 |
172 |
322 data analysis -- ipsilateral vs. contralateral [photographs, negative],
undated
|
| 51 |
173 |
323 LGU stimulation pathway [photographs, negative],
undated
|
| 51 |
174 |
324 3H standards calibration curves [photographs, negative],
undated
|
| 51 |
175 |
325 visual deprivation protein synthesis [photographs, negative],
undated
|
| 52 |
1 |
326 autoradiograph protein synthesis [photographs, negative],
undated
|
| 52 |
2 |
327 LGU other connections [photographs, negative],
undated
|
| 52 |
3 |
328 LGU: sensory-motor systems [photographs, negative],
undated
|
| 52 |
4 |
329 LGU: forebrain terminal areas [photographs, negative],
undated
|
| 52 |
5 |
330 electrode placements: contingent and non-contingent [photographs, negative],
undated
|
| 52 |
6 |
331 electrode placements: stimulated and non-stimulated [photographs, negative],
undated
|
| 52 |
7 |
332 3H methylglucose vs. 14C methylglucose [photographs, negative],
undated
|
| 52 |
8 |
333 3H DG vs. 14C DG [photographs, negative],
undated
|
| 52 |
9 |
334 morphine bar test and tail flick [photographs, negative],
undated
|
| 52 |
10 |
335 [photographs, negative],
undated
|
| 52 |
11 |
336 pineal body -- LGU monkey [photographs, negative],
undated
|
| 52 |
12 |
337 diazepam -- LGU [photographs, negative],
undated
|
| 52 |
13 |
338 TXW vs. control [photographs, negative],
undated
|
| 52 |
14 |
339 cretin vs. control [photographs, negative],
undated
|
| 52 |
15 |
340 TWX vs. control [photographs, negative],
undated
|
| 52 |
16 |
341 physiological parameters -- day vs. night and sleep vs. awake [photographs, negative],
undated
|
| 52 |
17 |
342 lesion -- lateral habenula -- LGU [photographs, negative],
undated
|
| 52 |
18 |
343 fetal sheep [photographs, negative],
undated
|
| 52 |
19 |
344 LGU in lateral habenula [photographs, negative],
undated
|
| 52 |
20 |
348 GHB -- anaerobic and aerobic [photographs, negative],
undated
|
| 52 |
21 |
349 neural structures regulating fluid balance [photographs, negative],
undated
|
| 52 |
22 |
350 GHB dehydrogenase inhibitors on tissue levels of GHB [photographs, negative],
undated
|
| 52 |
23 |
351 GHB -- synthesis and degradations pathways [photographs, negative],
undated
|
| 52 |
24 |
352 distribution of radioactivity after various stages of fractionation [photographs, negative],
undated
|
| 52 |
25 |
353 distribution of brain glycogen among fractions after extraction [photographs, negative],
undated
|
| 52 |
26 |
354 brain extraction scheme 1 [photographs, negative],
undated
|
| 52 |
27 |
355 brain extraction scheme 2 [photographs, negative],
undated
|
| 52 |
28 |
356 histaminergic sites influence on cerebral vessels [photographs, negative],
undated
|
| 52 |
29 |
357 neurotransmitter substances -- effect on pial arteriolar diameter [photographs, negative],
undated
|
| 52 |
30 |
358 encaphalocoele vs. control, striate cortex of monkey [photographs, negative],
undated
|
| 52 |
31 |
359 insulin -- effect on LGU [photographs, negative],
undated
|
| 52 |
32 |
360 hyperglycemia vs. normal -- LGU [photographs, negative],
undated
|
| 52 |
33 |
361 2-DG-6-PO4 and 2 DG-TLC of brain extracts [photographs, negative],
undated
|
| 52 |
34 |
362 LGU in ganglia during stimulation (H2) in urethane anesthesia [photographs, negative],
undated
|
| 52 |
35 |
363 probe track [photographs, negative],
undated
|
| 52 |
36 |
364 VTA stimulation [photographs, negative],
undated
|
| 52 |
37 |
365 VTA stimulation [photographs, negative],
undated
|
| 52 |
38 |
366 amphetamine -- LGU [photographs, negative],
undated
|
| 52 |
39 |
367 amphetamine -- locomotor and stereotypy scores [photographs, negative],
undated
|
| 52 |
40 |
368 amphetamine [photographs, negative],
undated
|
| 52 |
41 |
369 amphetamine [photographs, negative],
undated
|
| 52 |
42 |
370 amphetamine [photographs, negative],
undated
|
| 52 |
43 |
371 angiotensis II and saralasin [photographs, negative],
undated
|
| 52 |
44 |
372 angiotensinard saralasin [photographs, negative],
undated
|
| 52 |
45 |
373 apomorphine [photographs, negative],
undated
|
| 52 |
46 |
374 apomorphine [photographs, negative],
undated
|
| 52 |
47 |
375 subfornical organ and septal triangular N. -- LGU [photographs, negative],
undated
|
| 52 |
48 |
376 subformical organ and septal tricular N. -- LGU [photographs, negative],
undated
|
| 52 |
49 |
377 sheep LCGU -- pre and postnatal [photographs, negative],
undated
|
| 52 |
50 |
378 caffeine -- LGU [photographs, negative],
undated
|
| 52 |
51 |
379 caffeine -- LGU [photographs, negative],
undated
|
| 52 |
52 |
380 EAS [photographs, negative],
undated
|
| 52 |
53 |
381 female rats during cycle [photographs, negative],
undated
|
| 52 |
54 |
382 electrical stimulation on pineal gland [photographs, negative],
undated
|
| 52 |
55 |
383 female rats during cycle [photographs, negative],
undated
|
| 52 |
56 |
384 model I -- leucine traveling BBB [photographs, negative],
undated
|
| 52 |
57 |
385 percent change of protein synthesis, glucose utilization and relative twitch [photographs, negative],
undated
|
| 52 |
58 |
386 glucose utilization in menstruating rats [photographs, negative],
undated
|
| 52 |
59 |
387 postral calcarin fissure [photographs, negative],
undated
|
| 52 |
60 |
388 optic radiation tract section [photographs, negative],
undated
|
| 52 |
61 |
389 eye occlusion striate cortex [photographs, negative],
undated
|
| 52 |
62 |
390 ambient light markings, striate cortex [photographs, negative],
undated
|
| 52 |
63 |
391 eye occlusion lateral geniculate [photographs, negative],
undated
|
| 52 |
64 |
392 general equ. for measurement of reaction rates with tracers [photographs, negative],
undated
|
| 52 |
65 |
394 [125I] HIPDM and metabolic products in blood [photographs, negative],
undated
|
| 52 |
66 |
395 molecular structure of HIPDM [photographs, negative],
undated
|
| 52 |
67 |
396 [125I] HIPDM single pass extraction [photographs, negative],
undated
|
| 52 |
68 |
397 super optical nucleus, salt loading [photographs, negative],
undated
|
| 52 |
69 |
398 senescence [photographs, negative],
undated
|
| 52 |
70 |
399 maturescence [photographs, negative],
undated
|
| 52 |
71 |
400 LGU % change vs. stimulation frequency [photographs, negative],
undated
|
| 52 |
72 |
401 sciatic nerve stim. LGU in spinal cord and dorsal root ganglia [photographs, negative],
undated
|
| 52 |
73 |
402 water saturated vs. water deprived [photographs, negative],
undated
|
| 52 |
74 |
403 water sated vs. H2O deprived [photographs, negative],
undated
|
| 52 |
75 |
404 water sated vs. H2O deprived [photographs, negative],
undated
|
| 52 |
76 |
405 self-stimulation chapter [photographs, negative],
undated
|
| 52 |
77 |
406 self stim. cocaine/d-amphetamine/morphine [photographs, negative],
undated
|
| 52 |
78 |
407 criteria for adequate psychophysical threshold determination [photographs, negative],
undated
|
| 52 |
79 |
408 self stimulation [photographs, negative],
undated
|
| 52 |
80 |
409 self stim. % response vs. ua [photographs, negative],
undated
|
| 52 |
81 |
410 self stim. X Z score vs. dose [photographs, negative],
undated
|
| 52 |
82 |
411 running speed vs. log pulses per reward [photographs, negative],
undated
|
| 52 |
83 |
412 self-stimulation (graphic) [photographs, negative],
undated
|
| 52 |
84 |
413 response rate vs. intensity (base line drug) [photographs, negative],
undated
|
| 52 |
85 |
414a self stimulation pre/post responses [photographs, negative],
undated
|
| 52 |
86 |
414b acute dehydration [photographs, negative],
undated
|
| 52 |
87 |
415 acute dehydration [photographs, negative],
undated
|
| 52 |
88 |
416 (spinal cord ) acute dehydration [photographs, negative],
undated
|
| 52 |
89 |
417 adrenelectomy and dexamethason [photographs, negative],
undated
|
| 52 |
90 |
418 nerve stimulation -- dorsal root ganglion [photographs, negative],
undated
|
| 52 |
91 |
419 paraventricular nucleus -- acute adrenalectomy [photographs, negative],
undated
|
| 52 |
92 |
420 dehydration [photographs, negative],
undated
|
| 52 |
93 |
421 plasma and brain, deoxyglucose and deoxyglucose -- phosphate [photographs, negative],
undated
|
| 52 |
94 |
422 arterial plasma DG*/G vs. time [photographs, negative],
undated
|
| 52 |
95 |
423 pituitary neural lobe, water sated/water deprived [photographs, negative],
undated
|
| 52 |
96 |
424 septal triangular nucleus [negative],
undated
|
| 52 |
97 |
425 subfornical organ [photographs, negative],
undated
|
| 52 |
98 |
426 latero-lateral habenula [photographs, negative],
undated
|
| 52 |
99 |
427 spinal cord sciatic nerve stimulation [photographs, negative],
undated
|
| 52 |
100 |
428 plasma concentration (arterial and venous) vs. time [photographs, negative],
undated
|
| 52 |
101 |
429 pathways of glucose metabolism [photographs, negative],
undated
|
| 52 |
102 |
430 uptake of [32P] glucose-6-phosphate [photographs, negative],
undated
|
| 52 |
103 |
431 loss of label rates of [2-3H] glucose and [U14C] glucose in brain [photographs, negative],
undated
|
| 52 |
104 |
432 electrical stim. of sciatic nerve on LGU in spinal cord [photographs, negative],
undated
|
| 52 |
105 |
433 fractions of total tissue 14c content in form of free [14c] deoxyglucose in brain [photographs, negative],
undated
|
| 52 |
106 |
434 time courses of [14c] DG and 14c DG-6-P,
undated
|
| 52 |
107 |
435 measured and theoretical time courses of [14c] DG-6-P in brain [photographs, negative],
undated
|
| 52 |
108 |
436 arteriovenous differences of [14c] glucose and [14c] DG [photographs, negative],
undated
|
| 52 |
109 |
437 newborn lamb [photographs, negative],
undated
|
| 52 |
110 |
438 comparative rates of loss of label from 2-[3H] glucose and,
undated
|
| 52 |
111 |
439 nonacidic compounds w/vicinal cis diol. Groups [photographs, negative],
undated
|
| 52 |
112 |
442 effects of fasting on tissue levels of GHB [photographs, negative],
undated
|
| 52 |
113 |
443 biosynthesis of GHB by intact mitochondria [photographs, negative],
undated
|
| 52 |
114 |
444 rates of glucose utilization in rat cervical ganglion [photographs, negative],
undated
|
| 52 |
115 |
445 representative values for LCGU in conscious albino rat and monkey,
undated
|
| 52 |
116 |
446 [photographs, negative],
undated
|
| 52 |
117 |
447 cretin vs. control [photographs, negative],
undated
|
| 52 |
118 |
448 parasaggittal blindspot [photographs, negative],
undated
|
| 52 |
119 |
449 cretin vs. control [photographs, negative],
undated
|
| 52 |
120 |
450 cretin vs. control [photographs, negative],
undated
|
| 52 |
121 |
451 refused monkey cortical section [photographs, negative],
undated
|
| 52 |
122 |
454 E-cat scan of normal brain after injection of [18-F] fluorodeoxyglucose[photographs, negative],
undated
|
| 52 |
123 |
455 [photographs, negative],
undated
|
| 52 |
124 |
456 3H/14C ration in blood glucose [photographs, negative],
undated
|
| 52 |
125 |
457 pathways of GHB metabolism [photographs, negative],
undated
|
| 52 |
126 |
458 LGU in cervical ganglion [photographs, negative],
undated
|
| 52 |
127 |
459 [photographs, negative],
undated
|
| 52 |
128 |
460 simulation effects of frequency on LGU [photographs, negative],
undated
|
| 52 |
129 |
461 effects of acute dehydration on LBG in subfornical organ [photographs, negative],
undated
|
| 52 |
130 |
462 effects of acute dehydration on LGU in paracentricular nucleus [photographs, negative],
undated
|
| 52 |
131 |
463 effects of DD AVP on LGU of septaltriangular nucleus [photographs, negative],
undated
|
| 52 |
132 |
464 effects of DD AVP on LGU of lateral habenula nucleus, subfornical organ and paracentricular nucleus [photographs, negative],
undated
|
| 52 |
133 |
465 Krebs cycle [photographs, negative],
undated
|
| 52 |
134 |
466 Krebs cycles [photographs, negative],
undated
|
| 52 |
135 |
467 metabolism of carbohydrates [photographs, negative],
undated
|
| 52 |
136 |
468 metabolism of carbohydrate w/2-DG and 2-DG-6-P [photographs, negative],
undated
|
| 52 |
137 |
469 [photograph],
undated
|
| 52 |
138 |
470 G-6-P derivative of glucose fraction separated by chromatography [photographs, negative],
undated
|
| 52 |
139 |
471 separation of glucose by column and paper chromatography [photographs, negative],
undated
|
| 52 |
140 |
472 MPTP and L-DOPA [photographs, negative],
undated
|
| 52 |
141 |
473 MPTP and L-DOPA [photographs, negative],
undated
|
| 52 |
142 |
474 Estrus cycle [photographs, negative],
undated
|
| 52 |
143 |
475 dose dependent of methylphoedine [photographs, negative],
undated
|
| 52 |
144 |
476 DPTP and L-DOPA [photographs, negative],
undated
|
| 52 |
145 |
477 G-6-P and DG-6-P activities in rat tissues [photographs, negative],
undated
|
| 52 |
146 |
478 LGU in iodomethacin and dexamethasone [photographs, negative],
undated
|
| 52 |
147 |
479 radiochemical heterogeneity of eluate in Dowex-1-borate column [photographs, negative],
undated
|
| 52 |
148 |
480 theoretical time courses of [14c] DG-6-P in brain [photographs, negative],
undated
|
| 52 |
149 |
481 glucose-6-[32p] phosphate arterial and cerebral venous concentrations [photographs, negative],
undated
|
| 52 |
150 |
482 [14c] G-6-P single pass extraction fraction,
undated
|
| 52 |
151 |
484 time courses of [14C] DG and [14C] DG-6-P [photographs, negative],
undated
|
| 52 |
152 |
485 effects of antidromic stimulation on the rates of glucose utilization [photographs, negative],
undated
|
| 53 |
1 |
486 plasma concentration vs. rate constants [photographs, negative],
undated
|
| 53 |
2 |
487 difference in glucose utilization vs. frequency of stimulation (Hz) [photographs, negative],
undated
|
| 53 |
3 |
488 plasma glucose concentration vs. glucose infusion rate [photographs, negative],
undated
|
| 53 |
4 |
489 lumped constant at different plasma glucose levels [photographs, negative],
undated
|
| 53 |
5 |
490 arterial and venous concentrations [photographs, negative],
undated
|
| 53 |
6 |
491 self stimulation [photographs, negative],
undated
|
| 53 |
7 |
492 self stimulation II [photographs, negative],
undated
|
| 53 |
8 |
493 LGN in intact binocular vision vs. chronic monocular deprivation [photographs, negative],
undated
|
| 53 |
9 |
494 dorsal root ganglion [photographs, negative],
undated
|
| 53 |
10 |
495 monkey arm movement [photographs],
undated
|
| 53 |
11 |
496 estimation of rate constants for dephosphorylation [photographs, negative],
undated
|
| 53 |
12 |
497 LCGU in globus pallidus and subthalmic nucleus [photographs, negative],
undated
|
| 53 |
13 |
498 DG6P by NMR vs. DG6P [GC-MS] [photographs, negative],
undated
|
| 53 |
14 |
499 LCGU in sensorimotor cortex and ventromedial thalamus [photographs, negative],
undated
|
| 53 |
15 |
500 LCGU [photographs, negative],
undated
|
| 53 |
16 |
501 % change in G.U. from no stimulation control values [photographs, negative],
undated
|
| 53 |
17 |
502 % change in G.U. from no stimulation control values [photographs, negative],
undated
|
| 53 |
18 |
503 % change in GU (IPSI vs. contralateral) [photographs, negative],
undated
|
| 53 |
19 |
504 LCGU in medial prefrontal and anterior cingulated cortex [photographs, negative],
undated
|
| 53 |
20 |
505 % change in GU, anterior cingulated and dorsomedial caudate [photographs, negative],
undated
|
| 53 |
21 |
506 changes in metabolic activity during self-stimulation [photographs, negative],
undated
|
| 53 |
22 |
507 behaviors associated w/self-stimulation to the ventral mid brain [photographs, negative],
undated
|
| 53 |
23 |
508 concentrations of glucose, glycogen and lactate [photographs, negative],
undated
|
| 53 |
24 |
509 [14c] DG concentration in plasma, gray and white [photographs, negative],
undated
|
| 53 |
25 |
510 % of 14c as 14c-DG/amount of 14c-DGP found after single injection [photographs, negative],
undated
|
| 53 |
26 |
511 principle of the assay of glucose-6-P in vivo by selective detritiation of [2-3H]G [photographs, negative],
undated
|
| 53 |
27 |
512 incorporation of 2-[14c] deoxyglucose into glycogen a [photographs, negative],
undated
|
| 53 |
28 |
513 GU in control post-radiation: 4 days and 4 weeks [photographs, slides],
undated
|
| 53 |
29 |
514 glucose infusion rate[photographs, negative],
undated
|
| 53 |
30 |
515 lumped constant vs. arterial plasma glucose [photographs, negative],
undated
|
| 53 |
31 |
516 arterial plasma glucose concentration vs. duration of infusion [photographs, negative],
undated
|
| 53 |
32 |
517 determination of lumped constants during hyperglycemia state [photographs, negative],
undated
|
| 53 |
33 |
518 arterial plasma glucose concentration vs. rate constants in grey and white matter [photographs, negative],
undated
|
| 53 |
34 |
519 lumped constant vs. arterial plasma glucose concentration [photographs, negative],
undated
|
| 53 |
35 |
520 lack of uptake of [32p] G-6-P [photographs, negative],
undated
|
| 53 |
36 |
521 Hawkins brain, DG-6-P graphs [photographs, negative],
undated
|
| 53 |
37 |
522 stimulation of sciatic nerve [photographs, negative],
undated
|
| 53 |
38 |
523 cytochemical localization of G-6-P [photographs, negative],
undated
|
| 53 |
39 |
524 localization of G6-pase in a nerve cell [photographs, negative],
undated
|
| 53 |
40 |
525 effects of catecholamines of cerebral circulation and metabolism [photographs, negative],
undated
|
| 53 |
41 |
526 eye occlusion striate cortex [photographs, negative],
undated
|
| 53 |
42 |
527 control, Tx and Tx + warm [photographs, negative],
undated
|
| 53 |
43 |
528 effects of amphetamines on brain glucose metabolism D [photographs, negative],
undated
|
| 53 |
44 |
530 Ci*/cp* vs. real time (square wave experiment) [photographs, negative],
undated
|
| 53 |
45 |
531 influence of duration of experimental period on weighted ave G.U. [photographs, negative],
undated
|
| 53 |
46 |
532 Ci*/Cp* vs. stretch time [photographs, negative],
undated
|
| 53 |
47 |
533 Ci*/Cp* vs. real time [photographs, negative],
undated
|
| 53 |
48 |
534 operational equation with 5 rate constants [photographs, negative],
undated
|
| 53 |
49 |
535 LCGU vs. methylphenidate [photographs, negative],
undated
|
| 53 |
50 |
536 methlyphenidate [photographs, negative],
undated
|
| 53 |
51 |
537 LCGU vs. methylphenidate [photographs, negative],
undated
|
| 53 |
52 |
538 the localization of G-6-pase in nerve cell of cerebral cortex [photographs, negative],
undated
|
| 53 |
53 |
540 G-6-P localization in liver [photographs, negative],
undated
|
| 53 |
54 |
541 effects of L-DOPA treatment on LCGU [photographs, negative],
undated
|
| 53 |
55 |
542 L-DOPA effects on LCGU in normal and MPTP-treated monkeys [photographs, negative],
undated
|
| 53 |
56 |
543 % dephosphorylation vs. % dephosphorylation of DG-6-P [photographs, negative],
undated
|
| 53 |
57 |
544 stretch time vs. apparent distribution space in sensorimotor cortex [photographs, negative],
undated
|
| 53 |
58 |
545 weighted average tissue concentration [photographs, negative],
undated
|
| 53 |
59 |
546 Ci*(T)/Cp*(T) vs. stretch time in sensory cortex [photographs, negative],
undated
|
| 53 |
60 |
547 Ci*(T)/Cp*(T) vs. stretch time in hypothalamus [photographs, negative],
undated
|
| 53 |
61 |
548 substantia nigra (pars reticulate) [photographs, negative],
undated
|
| 53 |
62 |
549 N20 VOI % vs. min. of inhalation [photographs, negative],
undated
|
| 53 |
63 |
550 apparent distributions space vs. real time [photographs, negative],
undated
|
| 53 |
64 |
551 Ci*(T)/Cp* vs. real time (square wave experiments) [photographs, negative],
undated
|
| 53 |
65 |
552 body temp. vs. time (min. after injection) [photographs, negative],
undated
|
| 53 |
66 |
553 N moles GHB/g brain vs. dose of GHB (mg/kg) [photographs, negative],
undated
|
| 53 |
67 |
554 t (C at 0-60 min.) vs. dose of GHB (mg/kg) [photographs, negative],
undated
|
| 53 |
68 |
555 cerebral and cerebellar cortex [photographs, negative],
undated
|
| 53 |
69 |
556 white matter structures [photographs, negative],
undated
|
| 53 |
70 |
557 % error of prediction: s. colliculus, pontine gray matter and sunstantia nigra [photographs, negative],
undated
|
| 53 |
71 |
558 deep cerebral gray structures [photographs, negative],
undated
|
| 53 |
72 |
559 effect of L-gulonate or D-glucuronate in plasma disappearance curve (GHB) [photographs, negative],
undated
|
| 53 |
73 |
560 weighted LCGU vs. time conc. rem sleep [photographs, negative],
undated
|
| 53 |
74 |
561 % error of prediction [photographs, negative],
undated
|
| 53 |
75 |
562 rate constants [photographs, negative],
undated
|
| 53 |
76 |
563 model and equa. for estimation of rate constants for dephosphorylation [photographs, negative],
undated
|
| 53 |
77 |
565 weighted average tissue concentration [photographs, negative],
undated
|
| 53 |
78 |
566 pontine gray [photographs, negative],
undated
|
| 53 |
79 |
567 globus pallidus [photographs, negative],
undated
|
| 53 |
80 |
568 cerebellar cortex [photographs, negative],
undated
|
| 53 |
81 |
569 corpus callosum [photographs, negative],
undated
|
| 53 |
82 |
570 arterial plasma concentration [photographs, negative],
undated
|
| 53 |
83 |
571 arterial plasma concentration [photographs, negative],
undated
|
| 53 |
84 |
572 sensory cortex [photographs, negative],
undated
|
| 53 |
85 |
573 influence of duration of experimental period on weighted ave. G.U. [photographs, negative],
undated
|
| 53 |
86 |
574 total DG-6-P concentration,
undated
|
| 53 |
87 |
575 concentration -- weighted fraction of total time spent in rem sleep [photographs, negative],
undated
|
| 53 |
88 |
576 [14c] DG concentration vs. time [photographs, negative],
undated
|
| 53 |
89 |
577 relative 3H/14c (sample/injectant) [photographs, negative],
undated
|
| 53 |
90 |
578 labeled compounds remaining after hexokinase purification step [photographs, negative],
undated
|
| 53 |
91 |
579 pyrrolidone-5-carboxylate is a major contaminant of huang and veech ???????glucose' [photographs, negative],
undated
|
| 53 |
92 |
580 % total DPM and relative 3H/14C ratio [photographs, negative],
undated
|
| 53 |
93 |
581 labeled contaminants in huang and veech ???????glucose' [photographs, negative],
undated
|
| 53 |
94 |
582 lability of [2-3H, U-14C] glucose during purification,
undated
|
| 53 |
95 |
583 labeled compounds remaining after glucose oxidase purification step [photographs, negative],
undated
|
| 53 |
96 |
584 glucose purification [photographs, negative],
undated
|
| 53 |
97 |
585,
undated
|
| 53 |
98 |
586 LCGU in rem sleep [photographs, negative],
undated
|
| 53 |
99 |
587 LCGU vs. time concentration slow wave sleep [photographs, negative],
undated
|
| 53 |
100 |
588 washout correction experiment [photographs, negative],
undated
|
| 53 |
101 |
589 ulisse [photographs, negative],
undated
|
| 53 |
102 |
590 ulisse [photographs, negative],
undated
|
| 53 |
103 |
591 ulisse [photographs, negative],
undated
|
| 53 |
104 |
592 ulisse [photographs, negative],
undated
|
| 53 |
105 |
593 pet scan -- Italian [photographs, negative],
undated
|
| 53 |
106 |
594 cerebellar cortex [photographs, negative],
undated
|
| 53 |
107 |
595 internal capsule [photographs, negative],
undated
|
| 53 |
108 |
596 tissue 2DG and 2DG-6-P,
undated
|
| 53 |
109 |
597 relationship between cerebral oxygen consumption and G.U. [photographs, negative],
undated
|
| 53 |
110 |
598 body temp. vs. time [photographs, negative],
undated
|
| 53 |
111 |
599 lumped constant in several species [photographs, negative],
undated
|
| 53 |
112 |
600 rate constants for 3-0-methylglucose [photographs, negative],
undated
|
| 53 |
113 |
601 ratio of antibody to cytosol or to homogenate [photographs, negative],
undated
|
| 53 |
114 |
602 rate constants for dephosphorylation [photographs, negative],
undated
|
| 53 |
115 |
603 blood flow vs. age [photographs, negative],
undated
|
| 53 |
116 |
604 patlak plot [photographs, negative],
undated
|
| 53 |
117 |
605 equa. for estimation of rate constants for dephosphorylation [photographs, negative],
undated
|
| 53 |
118 |
606 GH B in cytosol [photographs, negative],
undated
|
| 53 |
119 |
607 GHB dehydrogenase vs. sod. valproate [photographs, negative],
undated
|
| 53 |
120 |
608 brain growth in different species in relation to birth [photographs, negative],
undated
|
| 53 |
121 |
609 parkisonian syndrome [photographs, negative],
undated
|
| 53 |
122 |
610 [14C] DG and [14C] DG-6-P concentration vs. time [photographs, negative],
undated
|
| 53 |
123 |
612 theoretical calculation of [14C] DG-6- P [photographs, negative],
undated
|
| 53 |
124 |
613 2 DG and rem sleep [photographs, negative],
undated
|
| 53 |
125 |
614 GHB activity vs. time [photographs, negative],
undated
|
| 53 |
126 |
615 time course of average brain DG-6-P concentration [photographs, negative],
undated
|
| 53 |
127 |
616 DG-6-P glucose clamp [photographs, negative],
undated
|
| 53 |
128 |
617 futile cycle associated w/ G6P (G6 pase) [photographs, negative],
undated
|
| 53 |
129 |
618 Huang and Beech TLC contaminants [photographs, negative],
undated
|
| 53 |
130 |
619 L-DG and enzyme [photographs, negative],
undated
|
| 53 |
131 |
620 SSA formed vs. pH [photographs, negative],
undated
|
| 53 |
132 |
621 SSA and [symbol] -- KG [photographs, negative],
undated
|
| 53 |
133 |
622 [symbol] -- KG, GHB and enzyme [photographs, negative],
undated
|
| 53 |
134 |
623 plasma glucose in normoglycemia [photographs, negative],
undated
|
| 53 |
135 |
625 plasma glucose in hyperglycemia [photographs, negative],
undated
|
| 53 |
136 |
626 pulse and square wave in S. N. [photographs, negative],
undated
|
| 53 |
137 |
627 pulse and sq. wave in sensory cortex [photographs, negative],
undated
|
| 53 |
138 |
628 pulse and sq. wave in dorsal thalamus [photographs, negative],
undated
|
| 53 |
139 |
629 pulse and sq. wave in whole brain [photographs, negative],
undated
|
| 53 |
140 |
630 pulse and sq. wave in cerebellar cortex [photographs, negative],
undated
|
| 53 |
141 |
631 pulse and sq. wave in hypothalamus [photographs, negative],
undated
|
| 53 |
142 |
632 pulse and sq. wave in internal capsule [photographs, negative],
undated
|
| 53 |
143 |
633 L-hydroxyglutaric acid TMS [photographs, negative],
undated
|
| 53 |
144 |
634 V-hydroxybutyric acid vs. temp. [photographs, negative],
undated
|
| 53 |
145 |
635 veech contaminants [photographs, negative],
undated
|
| 53 |
146 |
636 pontine gray (Pulse and SQ. Wave) [photographs, negative],
undated
|
| 53 |
147 |
637 plasma glucose in hypoglycemia [photographs, negative],
undated
|
| 53 |
148 |
638 veech column separation [photographs, negative],
undated
|
| 53 |
149 |
639 glucose utilization in sq. wave [photographs, negative],
undated
|
| 53 |
150 |
640 duration of experimental period on weighted G.U. (pulse) [photographs, negative],
undated
|
| 53 |
151 |
641 after derivatization of glucose w/ hexokinase and G. oxidase [photographs, negative],
undated
|
| 53 |
152 |
642 veech analysis of contaminants [photographs, negative],
undated
|
| 53 |
153 |
643 brain extract -- dowex (Veech) [photographs, negative],
undated
|
| 53 |
154 |
644 veech contaminants after separation [photographs, negative],
undated
|
| 53 |
155 |
645 plasma glucose vs. pulse and sq. wave [photographs, negative],
undated
|
| 53 |
156 |
646 rate constants vs. length of experiment [photographs, negative],
undated
|
| 53 |
157 |
647 CBF in normal mouse [photographs, negative],
undated
|
| 53 |
158 |
648 plasma glucose concentration in normoglycemia[photographs, negative],
undated
|
| 53 |
159 |
649 plasma glucose concentration in hypoglycemia [photographs, negative],
undated
|
| 53 |
160 |
650 plasma glucose concentration in hyperglycemia,
undated
|
| 54 |
1 |
651 cocaine / activity [photographs, negative],
undated
|
| 54 |
2 |
652 cocaine -- gluc. Util. vs. activity [photographs, negative],
undated
|
| 54 |
3 |
653 acute MPTP : olive [photographs, negative],
undated
|
| 54 |
4 |
654 MPTP acute : nigra [photographs, negative],
undated
|
| 54 |
5 |
655 mouse blood flow [photographs, negative],
undated
|
| 54 |
6 |
656 arithmetic average rate constants [photographs, negative],
undated
|
| 54 |
7 |
657 hypothalamus [photographs, negative],
undated
|
| 54 |
8 |
658 substantia nigra reticulata [photographs, negative],
undated
|
| 54 |
9 |
659 rate constants determined for cerebellar cortex [photographs, negative],
undated
|
| 54 |
10 |
660 rate constants -- SN ret. [photographs, negative],
undated
|
| 54 |
11 |
661 constants -- internal capsule [photographs, negative],
undated
|
| 54 |
12 |
662 rate constants -- hypothalamus [photographs, negative],
undated
|
| 54 |
13 |
663 arithmetic average rate constants for white matter [photographs, negative],
undated
|
| 54 |
14 |
664 mouse blood flow rate corrections [photographs, negative],
undated
|
| 54 |
15 |
665 LCBF VS. LCGU in normal mice [photographs, negative],
undated
|
| 54 |
16 |
666 LCBF VS. LCGU in normal mice [photographs, negative],
undated
|
| 54 |
17 |
667 cocaine -- activity vs. time after 2 DG. [photographs, negative],
undated
|
| 54 |
18 |
668 rate constants -- composite [photographs, negative],
undated
|
| 54 |
19 |
669 metabolites -- dowex -- 1 -- formate column [photographs, negative],
undated
|
| 54 |
20 |
670 methyl glucose plasma concentration vs. time [photographs, negative],
undated
|
| 54 |
21 |
671 elution of methylglucose [14C] vs. [U -- 14C ] [photographs, negative],
undated
|
| 54 |
22 |
672 hexokinase on dowex -- 1 -- formate effluent [photographs, negative],
undated
|
| 54 |
23 |
673 plasma glucose on dowex in normoglycemia and hyperglycemia [photographs, negative],
undated
|
| 54 |
24 |
674 cocaine LCGU vs. dose [photographs, negative],
undated
|
| 54 |
25 |
675 drugs and LCGU [photographs, negative],
undated
|
| 54 |
26 |
676 cocaine -- LCGU in nucl. acc. and SN.[photographs, negative],
undated
|
| 54 |
27 |
677 neurotransmitters and basal ganglia [photographs, negative],
undated
|
| 54 |
28 |
678 main connections of the nigrostriatal system [photographs, negative],
undated
|
| 54 |
29 |
679 diagram of basal ganglia [photographs, negative],
undated
|
| 54 |
30 |
680 [photographs, negative],
undated
|
| 54 |
31 |
682 hypergly. methyl glucose [photographs, negative],
undated
|
| 54 |
32 |
683 extractions of sugars [photographs, negative],
undated
|
| 54 |
33 |
684 % of 14C applied to dowex -- 1 -- formate column [photographs, negative],
undated
|
| 54 |
34 |
685 extraction of metabolites [photographs, negative],
undated
|
| 54 |
35 |
686 diagram of precursor pool [photographs, negative],
undated
|
| 54 |
36 |
687 10K model [photographs, negative],
undated
|
| 54 |
37 |
688 plasma glucose in hyperglycemia [photographs, negative],
undated
|
| 54 |
38 |
689 plasma glucose in normoglycemia [photographs, negative],
undated
|
| 54 |
39 |
690 plasma glucose in hypoglycemia [photographs, negative],
undated
|
| 54 |
40 |
691 5 rate constants model [photographs, negative],
undated
|
| 54 |
41 |
692 fractional rate of product loss [photographs, negative],
undated
|
| 54 |
42 |
693 LCGU vs. med. geniculate [photographs, negative],
undated
|
| 54 |
43 |
694 triopental and celiac ganglionectomy [photographs, negative],
undated
|
| 54 |
44 |
695 Gl. util. thiopental and celiac ganglionectomy [photographs, negative],
undated
|
| 54 |
45 |
696 G.U. thiopental and celiac ganglionectomy [photographs, negative],
undated
|
| 54 |
46 |
697 G.U. thiopental and celiac ganglionectomy [photographs, negative],
undated
|
| 54 |
47 |
698 lumped constants in normo and hypo glycemia [photographs, negative],
undated
|
| 54 |
48 |
699 lumped constants in normo, hypo and hyper glycemia [photographs, negative],
undated
|
| 54 |
49 |
700 lumped constants in arterial and venous concentration [photographs, negative],
undated
|
| 54 |
50 |
701 methylglucose sections [photographs, negative],
undated
|
| 54 |
51 |
702 statistical analysis, experiments w/ sq. wave [photographs, negative],
undated
|
| 54 |
52 |
703 rate constants used in calculation of LCGU [photographs, negative],
undated
|
| 54 |
53 |
704 statistical analysis experiments w/ pulse input [photographs, negative],
undated
|
| 54 |
54 |
705 arterial plasma concentration in exp. animals [photographs, negative],
undated
|
| 54 |
55 |
706 LCGU 3K and 4K models [photographs, negative],
undated
|
| 54 |
56 |
707 rate constants -- sq. wave and pulse [photographs, negative],
undated
|
| 54 |
57 |
708 methylglucose sections [photographs, negative],
undated
|
| 54 |
58 |
709 lumped constants w/ sq. wave [photographs, negative],
undated
|
| 54 |
59 |
710 plasma glucose on dowex -- normo, hypo and hyper glycemia [photographs, negative],
undated
|
| 54 |
60 |
711 extraction of metabolites [photographs, negative],
undated
|
| 54 |
61 |
712 recovered DPM [photographs, negative],
undated
|
| 54 |
62 |
713 recovery of sugars from dowex [photographs, negative],
undated
|
| 54 |
63 |
714 correction (Veech) for blood remaining in brain [photographs, negative],
undated
|
| 54 |
64 |
715 r vs. brain glucose concentration [photographs, negative],
undated
|
| 54 |
65 |
716 hexose distribution ratios vs. brain glucose level [photographs, negative],
undated
|
| 54 |
66 |
717 hexose distribution.ratios vs. plasma levels [photographs, negative],
undated
|
| 54 |
67 |
718 non -- acidic, non -- phosph. metabolites [photographs, negative],
undated
|
| 54 |
68 |
719 labeled Non -- acidic and non -- phosphor. metabolites [photographs, negative],
undated
|
| 54 |
69 |
720 phosphorylation coefficient vs. plasma concentration [photographs, negative],
undated
|
| 54 |
70 |
721 elodea cell summary [photographs, negative],
undated
|
| 54 |
71 |
722 methylglucose sections [photographs, negative],
undated
|
| 54 |
72 |
723 elodea cells [photographs, negative],
undated
|
| 54 |
73 |
724 methylglucose mouse [photographs, negative],
undated
|
| 54 |
74 |
725 methylglucose distribution ratio [photographs, negative],
undated
|
| 54 |
75 |
726 steady -- state methylgl. distribution ratio [photographs, negative],
undated
|
| 54 |
76 |
727 total tissue radioactivity [photographs, negative],
undated
|
| 54 |
77 |
728 rate constants estimated from DG and DG-6-P concentration [photographs, negative],
undated
|
| 54 |
78 |
729 rate constants estimated from total tissue radioactivity [photographs, negative],
undated
|
| 54 |
79 |
730 heterogeneous tissue [photographs, negative],
undated
|
| 54 |
80 |
731 rate constant for phosphorylation [photographs, negative],
undated
|
| 54 |
81 |
732 4K rate constants gray matter [photographs, negative],
undated
|
| 54 |
82 |
734 equilibrium MG tissue/ plasma [photographs, negative],
undated
|
| 54 |
83 |
735 time course of DG metabolites [photographs, negative],
undated
|
| 54 |
84 |
736 r vs. Ce [photographs, negative],
undated
|
| 54 |
85 |
737 lumped constant [photographs, negative],
undated
|
| 54 |
86 |
738 brain glucose util. in hyperglycemia [photographs, negative],
undated
|
| 54 |
87 |
739 monkey vs. cortex [photographs, negative],
undated
|
| 54 |
88 |
740 rate constants for various levels of hyperglycemia [photographs, negative],
undated
|
| 54 |
89 |
741 influence of rate constants on integrated pool S.P. [photographs, negative],
undated
|
| 54 |
90 |
744 lumped constant at various levels of hyperglycemia [photographs, negative],
undated
|
| 54 |
91 |
745 effects of hyperinsulinemia [photograph, negative],
undated
|
| 54 |
92 |
748 GHB and temp. vs. time [photographs, negative],
undated
|
| 54 |
93 |
757 [symbol] including equation [photograph],
undated
|
| 54 |
94 |
760 diagram of freely moving rat [photographs, negative],
undated
|
| 54 |
95 |
765 LCGU in sup. collic., cerebellar cortex, med. gen. and int. cap. [negative],
undated
|
| 54 |
96 |
766 LCGU in sup. collic. hypothalamus, int. cap. And rate constants [photographs, negative],
undated
|
| 54 |
97 |
777 autoradiographic film test [photographs, negative],
undated
|
| 54 |
98 |
779 L-thyroxine uptake by brain [photographs, negative],
undated
|
| 54 |
99 |
795 pictorial diagram, protein synth. [photograph],
undated
|
| 54 |
100 |
799 distribution of CO2 in cells [negative],
undated
|
| 54 |
101 |
800 CO2 fixation in cell cultures [photographs],
undated
|
| 54 |
102 |
801 DNA/stairs -- joke [photographs, negative],
undated
|
| 54 |
103 |
811 equation for deoxyglucose methods [photograph],
undated
|
| 54 |
104 |
812 functional anatomy of 2 DG equ. [photographs, negative],
undated
|
| 54 |
105 |
813 tower of matches -- Joke [photographs, negative],
undated
|
| 54 |
106 |
814 nut and bolt -- joke [photographs, negative],
undated
|
| 54 |
107 |
816 equation for Patlak plot [photograph],
undated
|
| 54 |
108 |
817 rates fo hexoses transport [photograph],
undated
|
| 54 |
109 |
818 time courses uptake [photograph],
undated
|
| 54 |
110 |
819 equilibrium of CH3-glucose tissue [photograph],
undated
|
| 54 |
111 |
820 Michaelis-Menten kinetics [photograph],
undated
|
| 54 |
112 |
821 reaction catalyzed by pyruvate carboxylate [photograph],
undated
|
| 54 |
113 |
823 DG-G-P concentration in tissue reflects true average of rates of phosphorylation [photograph],
undated
|
| 54 |
114 |
824 total mixed tissue of two compartments [photograph],
undated
|
| 54 |
115 |
825 effect of glutamine conc. In culture medium [photograph],
undated
|
| 54 |
116 |
826 effect of varying the timing of medium change [photograph],
undated
|
| 54 |
117 |
827 role of individual medium constituents [photograph],
undated
|
| 54 |
118 |
828 glutamine is source of glutamate in culture medium [photograph],
undated
|
| 54 |
119 |
829 destruction of cultures with a brief pulse of medium [photograph],
undated
|
| 54 |
120 |
830 destruction of cultures during medium change (buffer) [photograph],
undated
|
| 54 |
121 |
831 destruction of cell cultures: protection by NMDA [photograph],
undated
|
| 54 |
122 |
832 3-H dopamine uptake vs. concentration of antagonists [photograph],
undated
|
| 54 |
123 |
833 brief exposure to fresh medium (pulse) [photograph],
undated
|
| 54 |
124 |
834 dual pathway for the oxidation of [symbol]-hydrobutyrate [photograph],
undated
|
| 54 |
125 |
835 tech notes: whole-body autoradiographs of mouse for G-6-p-ase activities [photograph],
undated
|
| 54 |
126 |
836 release of dopamine by added ligands [photograph],
undated
|
| 54 |
127 |
837 effects of antagonists on resistance [photograph],
undated
|
| 54 |
128 |
838 percentage uptake of 3-H dopamine vs. concentration of agonists [photograph],
undated
|
| 54 |
129 |
839 effect of glutamine concentration In culture medium [photograph],
undated
|
| 54 |
130 |
840 release of 3-H dopamine from pre-labelled cultures [photograph],
undated
|
| 54 |
131 |
841 reaction catalyzed by the mitochondrial hydroxyacid oxoacid transhydrogenase [photograph],
undated
|
| 54 |
132 |
842 neurotransmitters production cycle [photograph],
undated
|
| 54 |
133 |
843 model of DG method including G-6 p-ase activity [photograph],
undated
|
| 54 |
134 |
844 lumped constant vs. arterial plasma glucose conc. [photograph],
undated
|
| 54 |
135 |
845 DG model including G-6-p-ase activity [photograph],
undated
|
| 54 |
136 |
846 DG model including G-6-p-ase activity,
undated
|
| 54 |
137 |
848 relationships among arterial plasma and brain G. concentration and CMRglc [photograph],
undated
|
| 54 |
138 |
849 apparent dist. Space (whole brain, pont. Gray, cerebral cortex) [photograph],
undated
|
| 54 |
139 |
850 apparent dist. Space (sub. nigra, sens. cortex, int. capsule [photographs, negative],
undated
|
| 54 |
140-146 |
851-857 scientific couns. [not photo],
undated
|
| 54 |
147 |
871 rt. hypoglossal nucleus and rt. nucleus tractus solitarius [photographs],
undated
|
| 54 |
148 |
872 MPTP -- treated and normal [photographs],
undated
|
| 54 |
149 |
873 human -- eyes open and closed [photographs],
undated
|
| 54 |
150 |
875 DG in working monkey spinal cord [photographs],
undated
|
| 54 |
151 |
887 LCGU spinal cord (monkey) [photographs],
undated
|
| 54 |
152 |
889 LCGU spinal cord [photographs],
undated
|
| 54 |
153 |
910 MPTP lab. of cerebral metabolism [photographs],
undated
|
| 54 |
154 |
943 monkey using left arm -- Cerebellum [photographs],
undated
|
| 54 |
155 |
944 monkey using left arm [photographs],
undated
|
| 54 |
156 |
945 paraventricular nucleus [photographs],
undated
|
| 54 |
157 |
946 superior cervical ganglia [photographs],
undated
|
| 54 |
158 |
947 whisker barrel [photographs],
undated
|
| 54 |
159 |
947 whisker barrel CBF paper [photographs, negative],
undated
|
| 54 |
160 |
948 methyl glucose in brain [photographs],
undated
|
| 54 |
161 |
949 monkey using left arm -- Parietal [photographs],
undated
|
| 54 |
162 |
958 pituitary [photographs],
undated
|
| 54 |
163 |
963 monkey using left arm [photographs],
undated
|
| 54 |
164 |
964 striate cortex [photographs],
undated
|
| 54 |
165 |
1001 postnatal change in cerebral blood flow,
undated
|
| 54 |
166 |
1002 phoenoxybenzamine [photograph],
undated
|
| 54 |
167 |
1012 monkey striate cortex (awake vs. sleep) [photographs],
undated
|
| 54 |
168 |
1013 hypoglossal nucleus and tractus solitarius [photographs],
undated
|
| 54 |
169 |
1014 adrenalectomy and dexamethasone [photographs],
undated
|
| 54 |
170 |
1062 monkey ocular dominance columns [photographs],
undated
|
| 54 |
171 |
1126 Joseph Barcroft on oxygen,
undated
|
| 54 |
172 |
1126 quote: oxygen required for work,
undated
|
| 54 |
173 |
1127 methylglucose equilibrium tissue,
undated
|
| 54 |
174 |
1127 pet diagram,
undated
|
| 54 |
175 |
1128 rate constants" for efflux of DG/phosphorylation",
undated
|
| 54 |
176 |
1129 behavior of DG in heterogeneous tissue,
undated
|
| 54 |
177 |
1130 equation for rate of GU,
undated
|
| 54 |
178 |
1131 behavior of DG in heterogeneous tissue,
undated
|
| 54 |
179 |
1132 heterogeneous model (no loss),
undated
|
| 54 |
180 |
1133 behavior of DG in heterogeneous tissue (no loss),
undated
|
| 54 |
181 |
1134 DG method assumptions,
undated
|
| 54 |
182 |
1135 Y CMR glc. vs. time,
undated
|
| 54 |
183 |
1136 K4 to K3 in simulated mixed tissue,
undated
|
| 54 |
184 |
1137 tissue concentration of DG, DG-6-P and radioactivity estimate with hetero tissue model,
undated
|
| 54 |
185 |
1138 homogeneous tissue: estimated DG, DG-6-P conc.,
undated
|
| 54 |
186 |
1139 DG, DG-6-P and radioactivity concentration For simulated heterogeneous tissue,
undated
|
| 54 |
187 |
1140 behavior of DG in heterogeneous tissue,
undated
|
| 54 |
188 |
1141 behavior of DG in homogeneous tissue and loss (4K),
undated
|
| 54 |
189 |
1142 behavior od DG in homogeneous tissue -- 3K,
undated
|
| 54 |
190 |
1143 design for experimental determining of glucose utilization rate,
undated
|
| 54 |
191 |
1144 equation for rate of glucose utilization,
undated
|
| 54 |
192 |
1145 heterogeneous vs. homogeneous -- CMR,
undated
|
| 54 |
193 |
1146 heterogeneity model for DG in tissue,
undated
|
| 54 |
194 |
1147 equation for rate of G.U. (no loss),
undated
|
| 54 |
195 |
1148 emperor's clothes -- quote,
undated
|
| 54 |
196 |
1149 truth / stumble -- quote,
undated
|
| 54 |
197 |
1150 rate constants for various arterial plasma,
undated
|
| 54 |
198 |
1151 model of DG method including G-6-P-ase,
undated
|
| 54 |
199 |
1161 methyl glucose dist. ratio [photographs, negative],
undated
|
| 54 |
200 |
1178 astroglial metabolism,
undated
|
| 54 |
201 |
1179 astroglial metabolism plus potassium,
undated
|
| 54 |
202 |
1180 monkey cortical area [photographs, negative],
undated
|
| 54 |
203 |
1181 MRI + PET in human [photographs],
undated
|
| 54 |
204 |
1185 diagram of AV exchange [photographs, negative],
undated
|
| 54 |
205 |
1186,
undated
|
| 54 |
206 |
1187 on the regulation of the blood supply of the brain,
undated
|
| 54 |
207 |
1189 amino acid incorporation,
undated
|
| 54 |
208 |
1190 regional [symbol] protein synthesis,
undated
|
| 54 |
209 |
1191 Vmax / Km for NADPH,
undated
|
| 54 |
210 |
1192 NADPH production,
undated
|
| 54 |
211 |
1193 kinetic constants for inhibition of GHB-dehydrogenase,
undated
|
| 54 |
212 |
1194 rate of transhydrogenase reaction,
undated
|
| 54 |
213 |
1195 stoichiometry of [symbol]-HB,
undated
|
| 54 |
214 |
1198A steady state ratios of [3H] in tissue pools to plasma,
undated
|
| 54 |
215 |
1200A time courses of plasma,
undated
|
| 54 |
216 |
1201A schematic of the definition of [symbol],
undated
|
| 54 |
217 |
1202 regional values of [symbol] in adult males,
undated
|
| 54 |
218 |
1203A effects of unilateral electrical stimulation,
undated
|
| 54 |
219 |
1204A effects of lt. thiopental anesthesia,
undated
|
| 54 |
220 |
1205A time course of plasma,
undated
|
| 54 |
221 |
1206A denominator of the operational equation,
undated
|
| 54 |
222 |
1207 values of [symbol] and rates of protein in adult male rat,
undated
|
| 54 |
223 |
1208 rate of leucine into protein,
undated
|
| 54 |
224 |
1209 equation of the L-[1-14C] leucine method,
undated
|
| 54 |
225 |
1210 higher brain functions in humans,
undated
|
| 54 |
226 |
1210A,
undated
|
| 54 |
227 |
1211 functional state on protein synthesis,
undated
|
| 54 |
228 |
1212 effects of aging on rates,
undated
|
| 54 |
229 |
1213 values of [symbol] WB in the rat,
undated
|
| 54 |
230 |
1214 effects of unilateral hypoglossal axotomy,
undated
|
| 54 |
231 |
1215 [psi] v. [symbol] in the whole brain,
undated
|
| 54 |
232 |
1216 L-[1-14C] leucine method,
undated
|
| 54 |
233 |
1217 constant C*p for a long experimental interval,
undated
|
| 54 |
234 |
1220 quote from W. Thomson,
undated
|
| 54 |
235 |
1221 substances affecting phosphofructokinase activity,
undated
|
| 54 |
236 |
1222 operational equation of the L-[1-14C] leucine method,
undated
|
| 54 |
237 |
1224 biochemical reaction in vivo,
undated
|
| 54 |
238 |
1225 human myelin basic proteins,
undated
|
| 54 |
239 |
1231,
undated
|
| 54 |
240 |
1232 cerebral blood flow (chat) [photographs, negative],
undated
|
| 54 |
241 |
1233 CBF vs. aging [photographs, negatives],
undated
|
| 54 |
242 |
1234 rCMRglc. vs. tme [photographs, negative],
undated
|
| 54 |
243 |
1235 rate constant vs. end time of last scan [photographs, negative],
undated
|
| 54 |
244 |
1236 K vs. end time of last scan [photographs],
undated
|
| 55 |
1 |
1237 rCMRglc. vs. time [photographs, negative],
undated
|
| 55 |
2 |
1238 gluc. util. vs. midscan time [photographs, negative],
undated
|
| 55 |
3 |
1239 glucose vs. fructose as phosphate donor [photographs, negative],
undated
|
| 55 |
4 |
1240 distribution of 14C in arterial metabolites [photographs, negative],
undated
|
| 55 |
5 |
1242 DG of metabolites levels vs. time of the pulse [photographs, negative],
undated
|
| 55 |
6 |
1243 DPM before and after acid hydrolysis [photographs, negative],
undated
|
| 55 |
7 |
1244 influence of 14C metabolites on G.U. in brain [photographs, negative],
undated
|
| 55 |
8 |
1245 steady state brain -- plasma distribution ratios [photographs, negative],
undated
|
| 55 |
9 |
1247 elution gradient, standards, ethanol extract [photographs, negative],
undated
|
| 55 |
10 |
1249 concentration of DG-6-P in incubation vs. G-1, 6-P-2 concentration [photographs, negative],
undated
|
| 55 |
11 |
1250 lumped constant -- DG vs. brain glucose content [photographs, negative],
undated
|
| 55 |
12 |
1251 gradient elution and ethanol extract,
undated
|
| 55 |
13 |
1252 metabolite concentration vs. incubation time [photographs, negative],
undated
|
| 55 |
14 |
1253 14C --labeled metabolites in ethanol extract [photographs, negative],
undated
|
| 55 |
15 |
1254 concentration of 14C compounds vs. time after DG pulse [photographs, negative],
undated
|
| 55 |
16 |
1256 Huxley quote on mathematics,
undated
|
| 55 |
17 |
1257 profile of acetate elution gradient [photographs, negative],
undated
|
| 55 |
18 |
1259 thiopental anesthesia,
undated
|
| 55 |
19 |
1260 rates of protein synthesis in adult male rat,
undated
|
| 55 |
20 |
1261 L-valine flooding -- protein synthesis, acid soluble pools,
undated
|
| 55 |
21 |
1262 L-valine flooding -- bound a.a. pools,
undated
|
| 55 |
22 |
1263 definition of [symbol],
undated
|
| 55 |
23 |
1264 value of [symbol] in hypoglossal axotomy,
undated
|
| 55 |
24 |
1265 determination of [symbol],
undated
|
| 55 |
25 |
1266 simple operational equation protein synthesis,
undated
|
| 55 |
26 |
1267 operational equation and definitions -- protein synthesis,
undated
|
| 55 |
27 |
1268 denominator of operational equation,
undated
|
| 55 |
28 |
1269 electrical stimulation of sciatic nerve on protein synthesis in spinal cord and DRG,
undated
|
| 55 |
29 |
1270 values of [symbol] in developing rat,
undated
|
| 55 |
30 |
1271 definition of [symbol] in steady state,
undated
|
| 55 |
31 |
1272 flow sheet diagram for protein synthesis experiments,
undated
|
| 55 |
32 |
1273 leucine in tissue pool vs. plasma specific act.,
undated
|
| 55 |
33 |
1274 design protein synthesis procedure to simplify equation,
undated
|
| 55 |
34 |
1275 thiopental anesthesia and protein synthesis,
undated
|
| 55 |
35 |
1276 controal and protacaval shunt [photographs, negative],
undated
|
| 55 |
36 |
1277 barbital foci in DG and MG [photographs, negatives],
undated
|
| 55 |
37 |
1278 penicillin focus in DG and MG [photographs, negatives],
undated
|
| 55 |
38 |
1279 developmental time course in kidney [photographs, negatives],
undated
|
| 55 |
39 |
1280 developmental time course in brain [photographs, negatives],
undated
|
| 55 |
40 |
1281 developmental time course in kidney [photographs, negatives],
undated
|
| 55 |
41 |
1282 developmental time course in brain [photographs, negatives],
undated
|
| 55 |
42 |
1283 antibody titration of GHBD in rat brain cytosol [photographs, negatives],
undated
|
| 55 |
43 |
1284 developmental time course in kidney [photographs, negatives],
undated
|
| 55 |
44 |
1285 developmental time course in brain [photographs, negatives],
undated
|
| 55 |
45 |
1286 [photographs, negatives],
undated
|
| 55 |
46 |
1287 effect of whisker stroking on blood flow in whisker-to-barrel pathway[photographs, negatives],
undated
|
| 55 |
47 |
1303 [photographs],
undated
|
| 55 |
48 |
1313 reaction sequence in amino acid incorporation into protein,
undated
|
| 55 |
49 |
1314 reaction sequence in amino acid incorporation into protein,
undated
|
| 55 |
50 |
1315 Lord Kelvin quote,
undated
|
| 55 |
51 |
1316 C. W. Roy and C. S. Sherrington quote,
undated
|
| 55 |
52 |
1317 cartoon by W. Miller,
undated
|
| 55 |
53 |
1325 cat brain [photographs, negative],
undated
|
| 55 |
54 |
1326 [photographs, negative],
undated
|
| 55 |
55 |
1327 homogeneous and heterogeneous tissue model [photographs, negative],
undated
|
| 55 |
56 |
1328 time course of measured radioactivity[photographs, negative],
undated
|
| 55 |
57 |
1329 superior colliculus and lateral geniculate nucleus [photographs, negative],
undated
|
| 55 |
58 |
1330 effect of n-monomethyl-L-arginine on mean arterial blood pressure in rats,
undated
|
| 55 |
59 |
1331 effect of unilaterail whisker stroking on blood flow in unstimulated side of whisker to barrel pathway,
undated
|
| 55 |
60 |
1332 effects of nitric oxide synthase inhibitors on arterial pressure,
undated
|
| 55 |
61 |
1333 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02,
undated
|
| 55 |
62 |
1334 Distribution of N-methyl-Larginine between blood and brain 10 minutes after I.V. pulse,
undated
|
| 55 |
63 |
1335 effects of systemic infusion of nitric oxide synthase inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stimulation,
undated
|
| 55 |
64 |
1336 effects of intra-cisternal infusion of nitroarginine methy ester on ICBF in whisker-barrel pathway during unilateral whisker stimulation in the unanesthetized rat,
undated
|
| 55 |
65 |
1337 summary,
undated
|
| 55 |
66 |
1338 effects of 5 percent carbon dioxide on physiological variables in rats,
undated
|
| 55 |
67 |
1339 effects of 5 percent C02 on physiological variables in rats following systemic administration of nitric oxide inhibitors,
undated
|
| 55 |
68 |
1340 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats,
undated
|
| 55 |
69 |
1341 [photographs, negative],
undated
|
| 55 |
70 |
1342 C. W. Roy and C. S. Sherrington quote,
undated
|
| 55 |
71 |
1346 Kt for brain: plasma glucose transport,
undated
|
| 55 |
72 |
1347 Kt for blood-brain barrier transport of glucose from methylglucose tissue:plasma distribution ratios,
undated
|
| 55 |
73 |
1348 relationship of equilibrium methylglucose tissue:plasma distribution ratio to tissue glucose content in brain,
undated
|
| 55 |
74 |
1349 effects of insulin on local rates of glucose utilization in conscious rat brain,
undated
|
| 55 |
75 |
1350 effects of insulin-induced hypoglycemia on local rates of cerebral glucose utilization in the rat,
undated
|
| 55 |
76 |
1351 brain glucose utilization in hyperglycemia [photographs, negative],
undated
|
| 55 |
77 |
1352 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain,
undated
|
| 55 |
78 |
1353 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain,
undated
|
| 55 |
79 |
1354 effects of altered arterial blood tensions of respiratory gases on cerebral blood flow and related functions in normal young men,
undated
|
| 55 |
80 |
1355 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats,
undated
|
| 55 |
81 |
1356 brain glucose concentration and lumped constant,
undated
|
| 55 |
82 |
1357 traits of portacaval-shunted rats,
undated
|
| 55 |
83 |
1358 calculation of the rate of glucose utilization in brain,
undated
|
| 55 |
84 |
1359 ammonia levels in control and portacaval-shunted rats,
undated
|
| 55 |
85 |
1360 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment,
undated
|
| 55 |
86 |
1361 steady state brain:plasma distribution ratios for [14C]methylglucose,
undated
|
| 55 |
87 |
1362 glucose and glycogen concentrations and brain:plasma distribution ratios for glucose treatment,
undated
|
| 55 |
88 |
1363 deoxyglucose and glucose,
undated
|
| 55 |
89 |
1364 comparison of levels of ammonia, glucose and glutamine in various portacaval-shunted rats,
undated
|
| 55 |
90 |
1365 glucose levels and lumped constant in portacaval shunted rats,
undated
|
| 55 |
91 |
1366 effects of NOS inhibitor on increases in CBF induced by C02 inhalation in anesthetized ventilated rats,
undated
|
| 55 |
92 |
1367 effects of chronic intraperitoneal administration of NO synthase inhibitor on enzyme activites in brain,
undated
|
| 55 |
93 |
1368 effects of systemic administration of NO synthase inhibitors on enzyme activities in brain,
undated
|
| 55 |
94 |
1369 effects of intracisternal administration of NO synthase inhibitor on enzyme activities in brain,
undated
|
| 55 |
95 |
1370 visual pattern discrimination task,
undated
|
| 55 |
96 |
1371 section of the optic tract and corpus callosum 'blinds' the right hemisphere,
undated
|
| 55 |
97 |
1373 theory -- at equilibrium the rates of transport of methylglucose (MG), v*, to and from the brain tissue are equal,
undated
|
| 55 |
98 |
1374 physiological variables before and after topical application of bicuculline and muscimol,
undated
|
| 55 |
99 |
1375 preliminary experiments to evaluate the influence of bicuculline and muscimol on ICMRglc and steady state brain:plasma distribution ratio for [14C]methylglucose,
undated
|
| 55 |
100 |
1376 fig. 1. Ce*/Cp* as function of Ce at Cp = 15.4 mM,
undated
|
| 55 |
101 |
1377 fig. 2. Ce*/Cp* as function of Ce at Cp = 9.5 mM,
undated
|
| 55 |
102 |
1378 fig. 3. Ce*/Cp* as function of Ce at Cp = 6.8 mM,
undated
|
| 55 |
103 |
1379 fig. 4. Ce*/Cp* as function of Ce at Cp = 5.6 mM,
undated
|
| 55 |
104 |
1380 fig. 5. Ce*/Cp* as function of Ce at Cp = 4.5 mM,
undated
|
| 55 |
105 |
1381 fig. 6. Combined results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization,
undated
|
| 55 |
106 |
1382 fig. 7. Combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and ICMRglc),
undated
|
| 55 |
107 |
1383 conclusions,
undated
|
| 55 |
108 |
1384 effects of chronic intraperitoneal administration of nitroarginine methyl ester (50mg/kg twice daily for 4 days) on increases in cerebral blood flow caused by breathing 5 percent C02,
undated
|
| 55 |
109 |
1385 effect of intracisternal administration of nitroarginine methyl ester on nitric oxide synthase in brain,
undated
|
| 55 |
110 |
1386 effect of chronic intraperitoneal administration of nitroarginine methyl ester on nitric oxide synthase in brain,
undated
|
| 55 |
111 |
1387 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative],
undated
|
| 55 |
112 |
1388 [14C]deoxyglucose autoradiographs of brain sections from a rat whose vibrissae on the left side were continually stroked [photographs, negative],
undated
|
| 55 |
113 |
1389 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-metylarginine or NG-nitroarginine on arterial blood pC02 and pH,
undated
|
| 55 |
114 |
1390 right-left differences in glucose utilization in primary motor (area 4) and premotor cortex (area 6) in unimanually active monkeys,
undated
|
| 55 |
115 |
1391 right-left percent differences in glucose utilization in primary and secondary somatosensory cortex in unimanually active monkeys,
undated
|
| 55 |
116 |
1392 effects of intravenous administration of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking,
undated
|
| 55 |
117 |
1393 effects of intracisternal administration of nitroarginine ME on ICBF in whisker-to-barrel pathway during unilateral whisker stroking,
undated
|
| 55 |
118 |
1394 assay conditions for brain nitric oxide synthase activity,
undated
|
| 55 |
119 |
1395 effects of intracisternal administration of artificial CSF and of nitroarginine on physiological variables in rats,
undated
|
| 55 |
120 |
1396 effects of nitric oxide synthase inhibitors on increases in cerebral blood flow caused by breathing 5 percent C02,
undated
|
| 55 |
121 |
1397 effect of unilateral whisker stroking on ICBF in whisker-to-barrel pathway (untreated rats),
undated
|
| 55 |
122 |
1398 effects of 5 percent C02 in inspired air on arterial pC02 and pH in normal control rats and in rats administered inhibitors of nitric oxide synthase intravenously,
undated
|
| 55 |
123 |
1399 effects of inhibition of nitric oxide synthesis by intravenous administration of NG-methylarginine or NG-nitroarginine on cerebral blood flow in conscious rats,
undated
|
| 55 |
124 |
1400 [conscious vs. anesthetized glucose utilization [photographs, negative],
undated
|
| 55 |
125 |
1401 relationships among glycolytic and oxidative rates of glucose utilization and ATP turnover,
undated
|
| 55 |
126 |
1402 kinetic basis for obligatory increase in lactate/pyruvate concentrations during increases in oxidative glucose metabolism,
undated
|
| 55 |
127 |
1403 relationship between oxygen and glucose metabolism in normal young adult human brain,
undated
|
| 55 |
128 |
1404 cerebral blood flow and metabolic rate in humans with various disorders affecting mental state,
undated
|
| 55 |
129 |
1406 relationship between cerebral oxygen consumption and glucose utilization in normal young adult man,
undated
|
| 55 |
130 |
1407 energy metabolism per spike in dorsal horn,
undated
|
| 55 |
131 |
1408 ICMRglc per spike in dorsal lumbar cord,
undated
|
| 55 |
132 |
1431astrocytes -- intracellular products,
undated
|
| 55 |
133 |
1432 astrocytes + MSO -- extracellular products,
undated
|
| 55 |
134 |
1433 astrocytes + MSO -- intracellular products,
undated
|
| 55 |
135 |
1434 astrocytes + neurons -- intracellular products,
undated
|
| 55 |
136 |
1435 astrocytes + neurons + MSO -- intracellular products,
undated
|
| 55 |
137 |
1436 astrocytes + neurons + MSO -- extracellular products,
undated
|
| 55 |
138 |
1437 astrocytes + neurons -- extracellular products,
undated
|
| 55 |
139 |
1438 astrocytes -- extracellular products,
undated
|
| 55 |
140 |
1439 [14C]products (DPM),
undated
|
| 55 |
141 |
1440 C02 fixation in primary CNS cultures,
undated
|
| 55 |
142 |
1441 astroglia vs. neurons and astroglia,
undated
|
| 55 |
143 |
1442 MIX-4: AAAnal IC and EC,
undated
|
| 55 |
144 |
1443 K+ concentrations of astroglia and neurons,
undated
|
| 55 |
145 |
1444 the effect of depolarizing agents on C02 fixation in astroglial cells,
undated
|
| 55 |
146 |
1445 the effect of calcium on C02 fixation in astroglial cells,
undated
|
| 55 |
147 |
1446 astroglia, fibroblasts, and neurons,
undated
|
| 55 |
148 |
1447 [14C]deoxyglucose concentration,
undated
|
| 55 |
149 |
1449 autoradiographic calibration [photographs, negatives],
undated
|
| 55 |
150 |
1450 Aristotle quote,
undated
|
| 55 |
151 |
1451 [14C]iodoantyiprine and [14C]deoxyglucose [photographs, negatives],
undated
|
| 55 |
152 |
1452 glucose utilization during unilateral spreading depression in left hemisphere [photographs, negatives],
undated
|
| 55 |
153 |
1453 percent activity newborn rat pup and 20 day rat pup [photographs, negatives],
undated
|
| 55 |
154 |
1454 postnatal age activity [photographs, negatives],
undated
|
| 55 |
155 |
1455 postnatal age activity [photographs, negatives],
undated
|
| 55 |
156 |
1456 postnatal age activity [photographs, negatives],
undated
|
| 55 |
157 |
1457 postnatal age and GHB and GABA concentrations [photographs, negatives],
undated
|
| 55 |
158 |
1458 postnatal age and GHB concentration [photographs, negatives],
undated
|
| 55 |
159 |
1459 postnatal age and activity [photographs, negative],
undated
|
| 55 |
160 |
1460 apomorphine and ICMRglc [photographs, negative],
undated
|
| 55 |
161 |
1461 [14C]iodoantipyrine autoradiographs of brain sections made from z-chloralose/urethane anesthetized rats [photographs, negative],
undated
|
| 55 |
162 |
1462 [photographs, negative],
undated
|
| 55 |
163 |
1463 blood pressure responses to stimulation during electrode placement under anesthesia [photographs, negative],
undated
|
| 55 |
164 |
1464 unilateral and bilateral lesions [photographs, negative],
undated
|
| 55 |
165 |
1465 blood pressure and biphasic stimulation [photographs, negative],
undated
|
| 55 |
166 |
1466 varied blood pressure and biphasic stimulation [photographs, negative],
undated
|
| 55 |
167 |
1467 blood pressure responses [photographs, negative],
undated
|
| 55 |
168 |
1468 unilateral and bilateral lesions [photographs, negative],
undated
|
| 55 |
169 |
1469 [14C]iodoantypyrine and [14C]deoxyglucose [photographs, negative],
undated
|
| 55 |
170 |
1470 [photographs, negative],
undated
|
| 55 |
171 |
1471 [photographs, negative],
undated
|
| 55 |
172 |
1472 postnatal age and ICPSleu [photographs, negative],
undated
|
| 55 |
173 |
1473 postnatal age and ICPSleu [photographs, negative],
undated
|
| 55 |
174 |
1474 postnatal age and CPSleu[photographs, negative],
undated
|
| 55 |
175 |
1475 effects of chronic intraperitoneal nitroarginine on baseline and on increases in blood flow due to unilateral whisker stroking in four stations of the whisker-to-barrel pathway [photographs, negative],
undated
|
| 55 |
176 |
1476 effects of intracisternally infused artificial CSF or nitroarginine on baseline and increases in blood flow due to unilateral stroking of whiskers in four stations of the whisker-to-barrel pathway [photographs, negative],
undated
|
| 55 |
177 |
1477 effects of intravenous nitroarginine on baseline and increases in blood flow in four stations of the whisker-to-barrel pathway due to unilateral stroking of whiskers [photographs, negative],
undated
|
| 55 |
178 |
1478 table 1. Effects of various treatments with nitroarginine on nitric oxide synthase activity in rat brain [photographs, negative],
undated
|
| 55 |
179 |
1481 effects of extracellular potassium ion concentration on phosphorylation of 2-deoxyglucose in cultured neurons and astroglia [title page?],
undated
|
| 55 |
180 |
1482 assay protocol,
undated
|
| 55 |
181 |
1483 standard reaction mixture,
undated
|
| 55 |
182 |
1484 conclusions,
undated
|
| 55 |
183 |
1485 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia,
undated
|
| 55 |
184 |
1486 cell cultures,
undated
|
| 55 |
185 |
1487 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose,
undated
|
| 55 |
186 |
1488 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deosyglucose in cultured astroglia,
undated
|
| 55 |
187 |
1489 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in astroglia,
undated
|
| 55 |
188 |
1490 effects of veratridine on phosphorylation of [14C]2-deoxyglucose,
undated
|
| 55 |
189 |
1491 effects of extracellular potassium ion concentration on phosphorylation of [14C[-2-deoxyglucose,
undated
|
| 55 |
190 |
1492 table 9. Cerebral blood flow and metabolic rate in humans with various disorders affecting mental state,
undated
|
| 55 |
191 |
1493 table 4. Effects of insulin hypoglycemia on cerebral circulation and metabolism in humans,
undated
|
| 55 |
192 |
1494 table 7. Effects of insulin in normoglycemia, insulin-induced hypoglycemia, and hyperglycemia on local cerebral glucose utilization in the rat,
undated
|
| 55 |
193 |
1495 table 1. Effects of infusions of 2-deoxyglucose (500 mg/kg) on physiological variables,
undated
|
| 55 |
194 |
1496 table 2. The effects of pharmacologic doses of 2-deoxyglucose (500 mg/kg) on local cerebral blood flow (ml/100 g/min),
undated
|
| 55 |
195 |
1497 Ca standards and Ca standard curve [photographs, negative],
undated
|
| 55 |
196 |
1498 Ca concentration gradients [photographs, negative],
undated
|
| 55 |
197 |
1499 Frank and Ernest cartoon (1994),
undated
|
| 55 |
198 |
1500 comic drawing of regions of the brain,
undated
|
| 55 |
199 |
1501 plasma calcium concentrations and clearance of 45Ca from plasma,
undated
|
| 55 |
200 |
1502 total calcium and integrated specific activity of 45Ca in arterial plasma as a function of age,
undated
|
| 55 |
201 |
1503 total brain concentration, brain:plasma distribution ratios, apparent transfer coefficients, and net uptake of calcium into hand-dissected brain regions as a function of age,
undated
|
| 55 |
202 |
1504 gradients of calcium transport in young, middle-aged, and old rats,
undated
|
| 55 |
203 |
1505 rank order of regional uptake of calcium as a function of age,
undated
|
| 55 |
204 |
1506 3-rate-constant (3K), 4-rate-constant (4K) model, and tissue heterogeneity (TH) model [negative],
undated
|
| 55 |
205 |
1507 3K, 4K, and TH models [negative],
undated
|
| 55 |
206 |
1508 3K model [negative],
undated
|
| 55 |
207 |
1509 relationship between accumulated labeled and unlabeled lactate in cerebral cortex during spreading depression,
undated
|
| 55 |
208 |
1510 3K, 4K, and TH models [negative],
undated
|
| 55 |
209 |
1511 specific activities of lactate and glucose as functions of brain glucose level in activated (spreading depression) and control cerebral cortex,
undated
|
| 55 |
210 |
1512 hypothetical reaction mechanism of enzymic NO formation,
undated
|
| 55 |
211 |
1513 conscious and anesthetized glucose utilization,
undated
|
| 55 |
212 |
1514 anonymous humorous quote,
undated
|
| 55 |
213 |
1515 left-right (spreading depression vs. control) differences obtained with labeled deoxyglucose and glucose,
undated
|
| 55 |
214 |
1516 brain:plasma distribution ratios for glucose (Ce/Cp) and [14C] deoxyglucose (Ce*/Cp*) and lambda (i.e., [Ce*/Cp*]/[Ce/Cp]) as functions of brain glucose content in warm- and cold-adapted, active control and hibernating squirrels,
undated
|
| 55 |
215 |
1517 clearance of [14C]DG from squirrel plasma after an intravenous pulse,
undated
|
| 55 |
216 |
1518 brain glucose level as a function of plasma glucose content in warm- and cold-adapted, active controls and hibernating squirrels,
undated
|
| 55 |
217 |
1519 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc,
undated
|
| 55 |
218 |
1520 direct chemical assays of concentrations of glucose, [14C]precursor, and 14C-labeled metabolites and calculated rates of glucose utilization in cerebral cortex during KCL-induced activation of CMRglc at 5-7 min after the pulse of [14C]precursor,
undated
|
| 55 |
219 |
1521 levels of glucose and [14C]deoxyglucose in plasma and several brain regions of active and hibernating squirrels at 45 min after a pulse of [14C]deoxyglucose,
undated
|
| 55 |
220 |
1523 brain:plasma distribution ratios for glucose and [14C]deoxyglucose and estimated values for the factor lambda and the lumped constant of the operational equation of the [14C]deoxyglucose method for active and hibernating squirrels,
undated
|
| 55 |
221 |
1524 separation of 14C-labeled metabolites derived from [6-14C]glucose in the control and activated cortex,
undated
|
| 55 |
222 |
1525 physiological variables in active and hibernating ground squirrels,
undated
|
| 55 |
223 |
1526 differences in metabolic rate with the mean rate of barrels A1-3 and E1-3 as reference,
undated
|
| 55 |
224 |
1527 metabolic rates in left (L) and right ( R) barrel cortex [negative],
undated
|
| 55 |
225 |
1528 effect of NO synthase inhibition on autoregulation [photographs, negative],
undated
|
| 55 |
226 |
1529 effects of intravenous infusion of epinephrine on physiological variables and CBF,
undated
|
| 55 |
227 |
1530 effects of glutamate on phosphorylation of [14C]2-deoxyglucose in cultured astroglia,
undated
|
| 55 |
228 |
1531 effects of veratridine or monensin on phosphorylation of [14C]2-deoxyglucose in cultured astroglia,
undated
|
| 55 |
229 |
1532 effects of veratridine on phosphorylation of [14C]2-deoxyglucose,
undated
|
| 55 |
230 |
1533 effects of veratridine on phosphorylation of [14C]2-deoxyglucose in cultured neurons and astroglia,
undated
|
| 55 |
231 |
1534 effects of dibutyryl cyclic AMP on phosphorylation of [14C]2-deoxyglucose in cultured astroglia,
undated
|
| 55 |
232 |
1535 effects of extracellular potassium ion concentration on phosophrylation of [14C]2-deoxyglucose in different types of cultured cells,
undated
|
| 55 |
233 |
1536 effects of chronic treatment with L-NAME on ICMRglc -- part 2,
undated
|
| 55 |
234 |
1537 effects of chronic treatment with L-NAME on ICMRglc -- part 1,
undated
|
| 55 |
235 |
1538 effect of NO synthase inhibition on autoregulation of CBF,
undated
|
| 55 |
236 |
1539 effects of extracellular potassium ion concentration on phosphorylation of [14C]2-deoxyglucose in cultured astroglia,
undated
|
| 55 |
237 |
1540 effects of cultivation period on phosphorylation of [14C]2-deoxyglucose in cultured astroglia,
undated
|
| 55 |
238 |
1541 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 1,
undated
|
| 55 |
239 |
1542 effects of chronic treatment with L-NAME on physiological variables,
undated
|
| 55 |
240 |
1543 effects of chronic treatment with L-NAME on physiological variables measured just prior to the infusion of [14C]deoxyglucose,
undated
|
| 55 |
241 |
1544 effects of chronic treatment with L-NAME on autoregulation of ICBF -- part 2,
undated
|
| 55 |
242 |
1545 effects of insulin on physiological variables and CBF in euglycemic rats,
undated
|
| 55 |
243 |
1546 effect of insulin-induced hypoglycemia on cerebral blood flow in conscious rats,
undated
|
| 55 |
244 |
1547 effect of pharmacological doses of deoxyglucose on CBF in conscious rats,
undated
|
| 55 |
245 |
1548 effect of insulin on cerebral blood flow in euglycemic rats,
undated
|
| 55 |
246 |
1549 relationship between CBF and [K+] in insulin-induced htypoglycemia,
undated
|
| 55 |
247 |
1550 relationship between arterial pH and CBF in insulin-induced hypoglycemia,
undated
|
| 55 |
248 |
1551 relationship between plasma lactate and CBF in insulin-induced hypoglycemia,
undated
|
| 55 |
249 |
1552 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat,
undated
|
| 55 |
250 |
1553 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat,
undated
|
| 55 |
251 |
1554 effects of NOS inhibitors on ICBF in whisker-to-barrel pathway during unilateral whisker stroking,
undated
|
| 55 |
252 |
1555 arterial plasma valine concentration [photographs, negative],
undated
|
| 55 |
253 |
1556 postnatal age and ICPSleu [photographs, negative],
undated
|
| 55 |
254 |
1557 arterial plasma insulin level, arterial plasma glucose concentration, and arterial plasma valine concentration [photographs, negative],
undated
|
| 55 |
255 |
1558 postnatal age and ICPSleu [photographs, negative],
undated
|
| 55 |
256 |
1559 acute, chronic, and residual cocaine and saline vehicle [photographs, negative],
undated
|
| 55 |
257 |
1560 behavioral scores and days of treatment for chronic vehicle and chronic cocaine [photographs, negative],
undated
|
| 55 |
258 |
1561 postnatal age and CPSleu [photographs, negative],
undated
|
| 55 |
259 |
1562 plasma, extracellular space, and intracellular space [photographs, negative],
undated
|
| 55 |
260 |
1563 lesion of fastigial nucleus and autoregulation of CBF [photographs, negative],
undated
|
| 55 |
261 |
1564 table 1. Physiological variables measured 45 seconds after starting stimulation and 15 seconds prior to the measurement of local cerebral blood flow or local cerebral glucose utilization,
undated
|
| 55 |
262 |
1565 table 2. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral blood flow,
undated
|
| 55 |
263 |
1566 table 3. Effects of electrical stimulation of the left cerebellar fastigial nucleus on local cerebral glucose utilization,
undated
|
| 55 |
264 |
1567 table 4. Effects of lesions of the cerebellar fastigial nucleus on physiological variables measured just before local cerebral blood flow measurement,
undated
|
| 55 |
265 |
1568 table 5. Effects of left unilateral lesion of the cerebellar fastigial nucleus on local cerebral blood flow,
undated
|
| 55 |
266 |
1569 table 6. Effects of lesions of the cerebellar fastigial nucleus on local cerebral blood flow,
undated
|
| 55 |
267 |
1570 effects of insulin-induced hypoglycemia on physiological variables and CBF in the rat,
undated
|
| 56 |
1 |
1571 table 3. Effects of increasing extracellular potassium ion concentration on rates of [14C]deoxyglucose phosphorylation in cultured astroglia [photographs, negative],
undated
|
| 56 |
2 |
1572 table 2. Influ4ence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro,
undated
|
| 56 |
3 |
1573 table 1. Representative values for local cerebral glucose utilization in normal conscious albino rat and monkey,
undated
|
| 56 |
4 |
1574 change in [14C] DG phospohrylation (percentage),
undated
|
| 56 |
5 |
1575 change in [14C] DG phospohrylation (percentage),
undated
|
| 56 |
6 |
1576 effect of pharmacological dose of doexyglucose on cerebral blood flow,
undated
|
| 56 |
7 |
1577 superior colliculus and lateral geniculate nucleus,
undated
|
| 56 |
8 |
1578 veratridine and monensin [photographs, negative],
undated
|
| 56 |
9 |
1579 neuronal, neuronal-astroglial, and astroglial extracellular potassium ion concentration [photographs, negative],
undated
|
| 56 |
10 |
1580 [14C]deoxyglucose-6-phosphate with and without glutamate [photographs, negative],
undated
|
| 56 |
11 |
1581 autoradiographic determination of concentrations of total 14C in activated (left) and control (right) cerebral cortex during unilateral KCL-induced activation of CMRglc,
undated
|
| 56 |
12 |
1582 loss of labeled metabolites of [6-14C]glucose during bilateral spreading cortical depression,
undated
|
| 56 |
13 |
1585 lactate loss from brain during bilateral spreading cortical depression+,
undated
|
| 56 |
14 |
1587 transport of 14C-labeled lactate and inulin in brain during a 10 min interval,
undated
|
| 56 |
15 |
1590 Ce*/Cp* as function of Ce at Cp = 5.6 mM,
undated
|
| 56 |
16 |
1591 combined experimental results: Ce*/Cp* as function of Ce when Ce is varied mainly by delivery or by the rate of glucose utilization,
undated
|
| 56 |
17 |
1592 nucleus accumbens and sensory motor cortex,
undated
|
| 56 |
18 |
1593 caudate-putamen and globus pallidus,
undated
|
| 56 |
19 |
1594 ventral N. thalamus and internal capsule,
undated
|
| 56 |
20 |
1595 average whole brain CBF and insulin-treated euglycemic,
undated
|
| 56 |
21 |
1596 average whole brain CBF with saline + DG and L-NAME + DG,
undated
|
| 56 |
22 |
1597 average whole brain CBF and arterial plasma glucose concentration (mM),
undated
|
| 56 |
23 |
1598 average whole brain CBF and arterial plasma glucose concentration (mM),
undated
|
| 56 |
24 |
1599 table 1. Effects of insulin on physiological variables measured just before CBF measurement,
undated
|
| 56 |
25 |
1600 table 2. Effects of insulin on physiological rats variables in euglycemic rats,
undated
|
| 56 |
26 |
1601 table 3. Effects of pharmacological doses of DG on physiological variables and CBF,
undated
|
| 56 |
27 |
1602 table 4. Effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats,
undated
|
| 56 |
28 |
1603 table 5. Effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement,
undated
|
| 56 |
29 |
1605 effects of insulin on physiological variables measured just before CBF measurement,
undated
|
| 56 |
30 |
1606 effects of insulin on physiological variables in euglycemic rats,
undated
|
| 56 |
31 |
1607 effects of pharmacological doses of DG on physiological variables and CBF,
undated
|
| 56 |
32 |
1608 effects of 2-DG and chronic treatment with L-NAME on physiological variables measured just before CBF measurement,
undated
|
| 56 |
33 |
1609 effects of chronic treatment with L-NAME on physiological variables in insulin-treated rats,
undated
|
| 56 |
34 |
1610 table 2. Effects of inhibitors of nitric oxide synthase on physiological variables during inhalation of room air or 5 percent C02,
undated
|
| 56 |
35 |
1612 distribution of [U-14C]lactate and its metabolites in brains of anesthetized rats at 10 min after an intracerebral injection,
undated
|
| 56 |
36 |
1613 effect of chronic intraperitoneal administration of nitroarginine on CBF and on increases in CBF produced by 5 percent C02,
undated
|
| 56 |
37 |
1614 conclusions,
undated
|
| 56 |
38 |
1619 newborn astroglia,
undated
|
| 56 |
39 |
1620 extracellular and intracellular astroglia and neurons,
undated
|
| 56 |
40 |
1640 effects of intravenous infusions of epiephrine on cerebral glucose utilization,
undated
|
| 56 |
41 |
1641 effects of intravenous infusions of epinephrine on cerebral blood flow,
undated
|
| 56 |
42 |
1642 effects of caffeine on CBF enhancement by insulin-induced hypoglycemia,
undated
|
| 56 |
43 |
1643 effects of glibenclamide on CBF enhancement by insulin-induced hypoglycemia,
undated
|
| 56 |
44 |
1644 CBF as a function of plasma glucose concentration,
undated
|
| 56 |
45 |
1645 CBF as a function of plasma glucose concentration,
undated
|
| 56 |
46 |
1646 CBF as a function of plasma glucose concentration,
undated
|
| 56 |
47 |
1647 CBF as a function of arterial glucose concentration,
undated
|
| 56 |
48 |
1648 CBF vs plasma glucose concentration in insulin-treated rats without and after pretreatment with nitroarginine,
undated
|
| 56 |
49 |
1649 effect of insulin on CBF in euglycemic rats,
undated
|
| 56 |
50 |
1650 arterial plasma glucose and catecholamines induced by glucoprivation due to insulin administration or pharmacological doses of deoxyglucose,
undated
|
| 56 |
51 |
1651 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by pharmacological doses of 2-deoxyglucose,
undated
|
| 56 |
52 |
1652 effects of acute and chronic nitroarginine pretreatment on CBF enhancement by insulin-induced hypogylcemia,
undated
|
| 56 |
53 |
1653 [14C]deoxyglucose-6-phosphate and glutamate [photographs],
undated
|
| 56 |
54 |
1654 effects of insulin on physiological variables in euglycemic rats,
undated
|
| 56 |
55 |
1655 diffusion-equilibrium blood flow model,
undated
|
| 56 |
56 |
1657 effects of caffeine on local cerebral blood flow during functional activation of whisker-barrel pathway,
undated
|
| 56 |
57 |
1658 calculated and measured methylglucose distribution ratio,
undated
|
| 56 |
58 |
1659 calculated and measured brain glucose content,
undated
|
| 56 |
59 |
1660 control of brain glucose level mainly by supply (constant demand),
undated
|
| 56 |
60 |
1661 control of brain glucose level mainly by demand (constant supply),
undated
|
| 56 |
61 |
1662 table 2. Influences of bicuculline and muscimol on rate of glucose utilization and methylglucose brain:plasma distribution ratio,
undated
|
| 56 |
62 |
1663 table 1. Physiological variables in animals studied with topical applications of bicuculline or muscimol,
undated
|
| 56 |
63 |
1664 diffusion-equilibrium blood flow model,
undated
|
| 56 |
64 |
1665 average whole brain CBF and glibenclamide,
undated
|
| 56 |
65 |
1666 average whole brain CBF and caffeine,
undated
|
| 56 |
66 |
1667 concluding remarks,
undated
|
| 56 |
67 |
1668 cerebral circulation and metabolism during deep sleep,
undated
|
| 56 |
68 |
1669 local cerebral glucose utilization in non-rapid eye movement sleep in monkeys,
undated
|
| 56 |
69 |
1670 cerebral circulation and metabolism during sleep and mental 'work',
undated
|
| 56 |
70 |
1671 cerebral circulation and metabolism in schizophrenia and LSD-induced psychotomimetic state,
undated
|
| 56 |
71 |
1672,
undated
|
| 56 |
72 |
1673 rates of leucine incorporation and weighted percentage time in deep sleep,
undated
|
| 56 |
73 |
1674 effects of catecholamines on cerebral circulation and metabolism,
undated
|
| 56 |
74 |
1675 protein synthesis in deep sleep,
undated
|
| 56 |
75 |
1676 table II. Cerebral nutritional insufficiency and mental state,
undated
|
| 56 |
76 |
1677 table IV. Cerebral circulation and metabolism in normal aging, arteriosclerosis and chronic brain syndrome,
undated
|
| 56 |
77 |
1679 hyperpolarization, relaxation, and vasodilation,
undated
|
| 56 |
78 |
1680 table 2. Relationship between oxygen and glucose metabolism in normal young adult human brain,
undated
|
| 56 |
79 |
1681 table 1. Substances utilized or produced by normal young adult human brain,
undated
|
| 56 |
80 |
1682 relationships among glycotic and oxidative rates of glucose utilization and ATP turnover in normal conscious human brain,
undated
|
| 56 |
81 |
1683 energy metabolism per spike,
undated
|
| 56 |
82 |
1684 energy metabolism per Hz,
undated
|
| 56 |
83 |
1686 table II Substrates of cerebral energy metabolism in human adults during prolonged starvation,
undated
|
| 56 |
84 |
1687 molecular layer of hippocampus,
undated
|
| 56 |
85 |
1688 cerebral blood flow,
undated
|
| 56 |
86 |
1689 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation,
undated
|
| 56 |
87 |
1690 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing,
undated
|
| 56 |
88 |
1691 spinal trigeminal nucleus, principal sensory trigeminal nucleus, VPM thalamic nucleus, and somatosensory cortex, barrel field [negatives],
undated
|
| 56 |
89 |
1692 cerebral blood flow [negatives],
undated
|
| 56 |
90 |
1693 table 1. Effects of scopolamine on physiological variables,
undated
|
| 56 |
91 |
1694 C. S. Roy and C. S. Sherrington quote,
undated
|
| 56 |
92 |
1695 C. S. Roy and C. S. Sherrington quote,
undated
|
| 56 |
93 |
1696 average whole brain CBF and caffeine and glibenclamide,
undated
|
| 56 |
94 |
1697 average whole brain CBF and arterial plasma glucose concentration,
undated
|
| 56 |
95 |
1698 table 1. Effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow,
undated
|
| 56 |
96 |
1699 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, and somatosensory cortex barrel field,
undated
|
| 56 |
97 |
1700 cerebellar white matter, caudate-putamen, primary motor cortex, and accumbens nucleus core,
undated
|
| 56 |
98 |
1701 table 2. Effects of insulin-induced bypoglycemia and pharmacological doses of 2-doexyglucose on adenosine, inosine, and hypoaxanthine levels in conscious rat brain,
undated
|
| 56 |
99 |
1702 weighted average whole brain blood flow and epinephrine,
undated
|
| 56 |
100 |
1703 table 1. Physiological variables and arteriovenous differences just prior to in situ freezing,
undated
|
| 56 |
101 |
1704 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism,
undated
|
| 56 |
102 |
1705 table 2. Metabolite levels in cerebral cortex before, during and following sensory stimulation,
undated
|
| 56 |
103 |
1707 resources -- Louis Sokoloff, M.D. -- Laboratory of Cerebral Metabolism,
undated
|
| 56 |
104 |
1708 compartmental models that do not meet the conditions for application of spectral analysis to total tissue activity,
undated
|
| 56 |
105 |
1709 compartmental models that satisfy the conditions for application of spectral analysis to total tissue activity,
undated
|
| 56 |
106 |
1710 compartmental systems formed by removing a link from a strongly connected noncyclic system,
undated
|
| 56 |
107 |
1711 construction of the sign-symmetric completion of a compartmental system,
undated
|
| 56 |
108 |
1712 strongly connected noncyclic compartmental systems,
undated
|
| 56 |
109 |
1713 residual intracellular 2-[14C]DG-6-P after extended incubation,
undated
|
| 56 |
110 |
1714 [14C] glucose standard, zero time, 5 minute incubation, 10 minute incubation, and 15 minute incubation,
undated
|
| 56 |
111 |
1715 phosphorylation reaction and phosphatase activity,
undated
|
| 56 |
112 |
1716 time course of 3H/14C ratio during incubation of astroglia with [2-3H]Glucose and [U-14C]glucose,
undated
|
| 56 |
113 |
1717 residual intracellular 2-[14C]DG-6-P after extended incubation,
undated
|
| 56 |
114 |
1718 active and hibernating effluent volumes,
undated
|
| 56 |
115 |
1719 ribosomes and [3H]-leucine incorporation,
undated
|
| 56 |
116 |
1720 active and hibernating [3H]-leucine incorporation,
undated
|
| 56 |
117 |
1721 molecular mechanisms in physiological regulation of cerebral blod flow and metabolism [title page?],
undated
|
| 56 |
118 |
1722 background,
undated
|
| 56 |
119 |
1723 effects of insulin-induced hypoglycemia, insulin administration under euglycemic conditions, and opharmacologic doses of 2-deoxyglucose on systemic physiological variables that might influence cerebral blood flow,
undated
|
| 56 |
120 |
1724 effects of insulin-induced hypoglycemia, insulin administratio nunder euglycemic conditions and pharmacologic doses of 2-deoxyglucose on blood constituents and global cerebral blood flow,
undated
|
| 56 |
121 |
1725 recent and current research,
undated
|
| 56 |
122 |
1726 conclusions,
undated
|
| 56 |
123 |
1728 active and hibernating [3H]-leucine incorporation,
undated
|
| 56 |
124 |
1729 intracellular 14C DPM and 3H DPM distances from origin,
undated
|
| 56 |
125 |
1730 intracellular and extracellular 14C DPM per [symbol]g protein,
undated
|
| 56 |
126 |
1731 intracellular 14C DPM distances from origin,
undated
|
| 56 |
127 |
1732 intracellular and extracellular 14C DPM per [symbol]g protein,
undated
|
| 56 |
128 |
1733 table3. Relationship between cerebral oxygen consumption and glucose utilization in a normal young adult man,
undated
|
| 56 |
129 |
1734 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time,
undated
|
| 56 |
130 |
1735 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time,
undated
|
| 56 |
131 |
1736 intracellular and extracellular 14C DPM per [symbol]g protein,
undated
|
| 56 |
132 |
1737 intracellular 14C DPM distances from origin,
undated
|
| 56 |
133 |
1738 extracellular 14C DPM distances from origin,
undated
|
| 56 |
134 |
1739 intracellular and extracellular 14C DPM per [symbol]g protein,
undated
|
| 56 |
135 |
1740 intracellular [2-3H-glucose / [U-14C]glucose ratio incubation time,
undated
|
| 56 |
136 |
1741 intracellular 14C DPM and 3H DPM distances from origin,
undated
|
| 56 |
137 |
1742 table 1. Physiological variables immediately before measurement of cerebral blood flow,
undated
|
| 56 |
138 |
1743 table 2. Effects of caffeine on CBF during sitmulation of vibrissae on left side of face in structures outside whisker-barrel pathway,
undated
|
| 56 |
139 |
1744 table 3. Effects of caffeine on activation of local cerebral glucose utilization (ICMRglc) by vibrissal stimulation in whisker-to-barrel cortex sensory pathway,
undated
|
| 56 |
140 |
1745 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex,
undated
|
| 56 |
141 |
1746 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex,
undated
|
| 56 |
142 |
1747 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex,
undated
|
| 56 |
143 |
1748 intracellular 14C DPM and 3H DPM distances from origin,
undated
|
| 56 |
144 |
1749 intracellular and extracellular 14C DPM per [symbol]g protein,
undated
|
| 56 |
145-148 |
1750-1753 extracellular 14C DPM distances from origin,
undated
|
| 56 |
149 |
1754 time courses of intracellular and extracellular 14C contents -- standard assay conditions,
undated
|
| 56 |
150 |
1755 extracellular 14C DPM distances from origin,
undated
|
| 56 |
151 |
1756 spinal trigeminal nucleus, principal sensory trigeminal nucleus, ventral posteromedial thalamic nucleus, barrel field of sensory cortex,
undated
|
| 56 |
152 |
1757 table 1. Physiological variables immediately before measurement of cerebral blood flow,
undated
|
| 56 |
153 |
1758 diffusion-equilibrium blood flow model,
undated
|
| 56 |
154 |
1759 table 1. The effect of extracellular potassium concentration on lactate formation in astroglial cells in culture,
undated
|
| 56 |
155 |
1760 table 2. The effect of extracellular potassium on C02 fixation and on lactate formation in astroglial cells in culture,
undated
|
| 56 |
156 |
1761 table 3. Products formed by astroglial cells incubated with 14C-labeled bicarbonate: the effect of increased extracellular potassium,
undated
|
| 56 |
157 |
1762 table 4. Glucose utilization in cells in culture,
undated
|
| 56 |
158 |
1763 table 5. The effect of L-lactate on the oxidation of D-Glucose (2.5mM) to C02,
undated
|
| 56 |
159 |
1764 table 6. The effect of D-Glucose on the oxidation of L-lactate (2mM) to C02,
undated
|
| 56 |
160 |
1765 Ce*/Cp* as function of Ce at Cp = 6.8 mM,
undated
|
| 56 |
161 |
1766 Ce/Cp* as function of Ce at Cp = 4.5 mM,
undated
|
| 56 |
162 |
1767 frequency of stimulation of glucose utilization [photographs, negative],
undated
|
| 56 |
163 |
1768 functioal plasticity in barrel cortex after depression,
undated
|
| 56 |
164 |
1769 combined theoretical values for Ce as function of Ce*/Cp* and Cp (control of Ce by delivery and CMRglc),
undated
|
| 56 |
165 |
1770 selective trapping of 45Ca during metabolic activation [photograph],
undated
|
| 56 |
166 |
1771 selective trapping of 45Ca during metabolic activation [photograph],
undated
|
| 56 |
167 |
1772 effect of unilateral visual stimulation on glucose utilization, effect of visual stimulation on the increase in glucose utilization in superior colliculus, relative increase in glucose utilization in stimulated superior colliculus,
undated
|
| 56 |
168 |
1773 table 1. Influence of sodium pump activity and neurosecretion on [14C]deoxyglucose uptake in posterior pituitary in vitro,
undated
|
| 56 |
169 |
1774 diagram of veins and sinuses of the human brain [photograph],
undated
|
| 60 |
1 |
071053 -- autoradiographs,
undated
|
| 60 |
2 |
071753A -- RA9 [photograph, negative],
undated
|
| 60 |
3 |
071753A -- 10 [photograph, negative],
undated
|
| 60 |
4 |
071753A -- 17 [photograph, negative],
undated
|
| 60 |
5 |
071753A -- 26 [photograph, negative],
undated
|
| 60 |
6 |
071753A -- RA27 [photograph, negative],
undated
|
| 60 |
7 |
071753A -- RA29 [photograph, negative],
undated
|
| 60 |
8 |
071753B [photographs, negatives],
undated
|
| 60 |
9 |
072453A #1 [photograph, negative],
undated
|
| 60 |
10 |
072453A #2 [photograph, negative],
undated
|
| 60 |
11 |
072453A #3 [photograph, negative],
undated
|
| 60 |
12 |
072453A #5 [photograph, negative],
undated
|
| 60 |
13 |
072453A [photograph, negative],
undated
|
| 60 |
14 |
072453A [photograph, negative],
undated
|
| 60 |
15 |
072453A [photograph, negative],
undated
|
| 60 |
16 |
072453B -- no densitometry [photograph, negative],
undated
|
| 60 |
17 |
072453B #4 RA6 [negative],
undated
|
| 60 |
18 |
073053A #1 [photograph, negative],
undated
|
| 60 |
19 |
073053A #2 [photograph, negative],
undated
|
| 60 |
20 |
073053A #3 [photograph, negative],
undated
|
| 60 |
21 |
073053A #5 [photograph, negative],
undated
|
| 60 |
22 |
073053A #6 [photograph, negative],
undated
|
| 60 |
23 |
073053A #7 [photograph, negative],
undated
|
| 60 |
24 |
073053A #8 [photograph, negative],
undated
|
| 60 |
25 |
073053B -- 9 [photograph, negative],
undated
|
| 60 |
26 |
073053B -- 10 [photograph, negative],
undated
|
| 60 |
27 |
073053B -- 11 [photograph, negative],
undated
|
| 60 |
28 |
073053B -- 12 [photograph, negative],
undated
|
| 60 |
29 |
073053B -- 13 [photograph, negative],
undated
|
| 60 |
30 |
073053B -- 14 [photograph, negative],
undated
|
| 60 |
31 |
073053B -- 15 [photograph, negative],
undated
|
| 60 |
32 |
073053B -- 16 [photograph, negative],
undated
|
| 60 |
33 |
080653A -- AR17 [photograph, negative],
undated
|
| 60 |
34 |
080653A -- AR18 [photograph, negative],
undated
|
| 60 |
35 |
080653A -- AR19 [photograph, negative],
undated
|
| 60 |
36 |
080653A -- AR20 [photograph, negative],
undated
|
| 60 |
37 |
080653A -- AR21 [photograph, negative],
undated
|
| 60 |
38 |
080653A -- AR22 [photograph, negative],
undated
|
| 60 |
39 |
080653A -- AR23 [photograph, negative],
undated
|
| 60 |
40 |
080653A -- AR24 [photograph, negative],
undated
|
| 60 |
41 |
080653A -- AR25 [photograph, negative],
undated
|
| 60 |
42 |
080653A -- AR26 [photograph, negative],
undated
|
| 60 |
43 |
080653A -- AR27 [negative],
undated
|
| 60 |
44 |
080653A -- AR28 [photograph, negative],
undated
|
| 60 |
45 |
080653A -- AR29 [photograph, negative],
undated
|
| 60 |
46 |
080653B [photographs, negatives],
undated
|
| 60 |
47 |
081353 [negatives],
undated
|
| 60 |
48 |
5613001 -- cat 40s-10 [negative],
undated
|
| 60 |
49 |
5613002 -- 3 C02-10 [negative],
undated
|
| 60 |
50 |
5613003 -- 5 C02-10 [negative],
undated
|
| 60 |
51 |
5613004 -- 3 02-10 [negative],
undated
|
| 60 |
52 |
5613005 -- 2 C02-10 [negative],
undated
|
| 60 |
53 |
5613006 -- CT6 C02-10 [negative],
undated
|
| 60 |
54 |
5613007 -- 6 C02-10; 4 02-10 [negative],
undated
|
| 60 |
55 |
5613008 -- 4 C0-10 [negative],
undated
|
| 60 |
56 |
564102 [negative],
undated
|
| 60 |
57 |
564103 [negative],
undated
|
| 60 |
58 |
564104 [negative],
undated
|
| 60 |
59 |
564105 [negative],
undated
|
| 60 |
60 |
564106 [negative],
undated
|
| 60 |
61 |
564101 [negative],
undated
|
| |
Cat,
1953-1957, undated [subseries]:
|
| 60 |
62 |
5612701 -- cat 5 W2-5 [negative],
undated
|
| 60 |
63 |
5612702 -- cat SCL 2 [negative],
undated
|
| 60 |
64 |
5612703 -- cat SCL 4 [negative],
undated
|
| 60 |
65 |
5612704 -- cat 102-10 [negative],
undated
|
| 60 |
66 |
5612705 -- cat SCL 8 [negative],
undated
|
| 60 |
67 |
5612706 -- cat SCL 15 [negative],
undated
|
| 60 |
68 |
5612707 -- cat 202-10 [negative],
undated
|
| 60 |
69 |
5612708 -- cat 1 C02-5 [negative],
undated
|
| 60 |
70 |
5612709 -- cat SCL 6 [negative],
undated
|
| 60 |
71 |
5612710 -- cat SCL 3 [negative],
undated
|
| 60 |
72 |
5612711 -- cat SCL 4 [negative],
undated
|
| 60 |
73 |
5612712 -- cat 1 C02-10 [negative],
undated
|
| 60 |
74 |
5612713 -- control cat 2 02-10, 1 C02-10 [negative],
undated
|
| 60 |
75 |
5612714 -- cat 4 C02-5 [negative],
undated
|
| 60 |
76 |
5612715 -- cat 5 SCL [negative],
undated
|
| 60 |
77 |
5612716 -- cat 2 C02-5 [negative],
undated
|
| 60 |
78 |
5612717 -- cat 14 SCL [negative],
undated
|
| 60 |
79 |
5612718 -- cat 3 C02-5 [negative],
undated
|
| 60 |
80 |
5612719 -- cat 13 SCL [negative],
undated
|
| 60 |
81 |
5612720 -- cat SCL 12 [negative],
undated
|
| 60 |
82 |
5612721 -- cat SCL 1 [negative],
undated
|
| 60 |
83 |
5612722 -- cat 6 C02-5 [negative],
undated
|
| 60 |
84 |
Cat no. 1 -- [negatives],
12/3/1953
|
| 60 |
85 |
Cat no. 2 [negatives],
undated
|
| 60 |
86 |
Cat no. 3 -- [negatives],
12/17/1953
|
| 60 |
87 |
Cat no. 4 -- [negatives],
12/17/1953
|
| 60 |
88 |
Cat no. 5 -- [negatives],
1/7/1954
|
| 60 |
89 |
Cat no. 6 -- [negatives],
1/7/1954
|
| 60 |
90 |
Cat no. 7 -- [negatives],
1/14/1954
|
| 60 |
91 |
Cat no. 7 and 8 -- heart and kidney [negatives],
undated
|
| 60 |
92 |
Cat no. 8 -- [negatives],
1/14/1954
|
| 60 |
93 |
Cat no. 9 -- [negatives],
2/4/1954
|
| 60 |
94 |
Cat no. 10 -- [negatives],
2/4/1954
|
| 60 |
95 |
Cat no. 11 -- [negatives],
2/11/1954
|
| 60 |
96 |
Cat no. 12 -- [negatives],
2/11/1954
|
| 60 |
97 |
Cat no. 13 -- saturation (#2 and 22 taken 5/21/57) [negatives],
2/12/1954; 5/21/1957
|
| 60 |
98 |
Cat no. 14 -- saturation (#9 taken 5/21/57) [negatives],
2/12/1954; 5/21/1957
|
| 60 |
99 |
Cat no. 15 -- cochlea destroyed [negatives],
2/25/1954
|
| 60 |
100 |
Cat no. 16 -- cochlea destroyed [negatives],
2/25/1954
|
| 60 |
101 |
Cat no. 17 -- cochlea destroyed [negatives],
3/4/1954
|
| 60 |
102 |
Cat no. 18 -- cochlea destroyed [negatives],
3/4/1954
|
| 60 |
103 |
Cat no. 19 -- [negatives],
5/20/1954
|
| 60 |
104 |
Cat no. 20 -- [negatives],
5/20/1954
|
| 60 |
105 |
Cat no. 21 -- lambda [negatives],
5/29/1954
|
| 60 |
106 |
Cat no. 23 -- [negatives],
6/3/1954
|
| 60 |
107 |
Cat no. 23 -- lambda [negatives],
6/3/1954
|
| 60 |
108 |
Cat no. 24 - (#11 and 16 in slides) [negatives],
6/3/1954
|
| 60 |
109 |
Cat no. 25 -- repeat (air exposure) [negatives],
6/9/1954
|
| 60 |
110 |
Cat no. 26 -- [negatives],
6/9/1954
|
| 60 |
111 |
Cat no. 26 -- reput [negatives],
6/9/1954
|
| 60 |
112 |
Cat no. 27 [negatives],
6/17/1954
|
| 60 |
113 |
Cat no. 28 [negatives],
6/17/1954
|
| 60 |
114 |
Cat no. 29 [negatives],
6/24/1954
|
| 60 |
115 |
Cat no. 30 [negatives],
6/24/1954
|
| 60 |
116 |
Cat no. 31 -- films 41, 45, 49 taken for England [negatives],
7/1/1954
|
| 60 |
117 |
Cat no. 32 [negatives],
7/1/1954
|
| 60 |
118 |
Cat no. 33 [negatives],
7/8/1954
|
| 60 |
119 |
Cat no. 34 -- for illustrations #17 and 20 in slides [negatives],
7/18/1954
|
| 60 |
120 |
Cat no. 35 -- lampda [negatives],
6/9/1954
|
| 60 |
121 |
Cat no. 35 -- [negatives],
7/15/1954
|
| 60 |
122 |
Cat no. 36 -- (#45 to England) [negatives],
7/15/1954
|
| 58 |
1 |
Cat 1 02 10 [negatives],
undated
|
| 58 |
2 |
Cat 2 02-10 [negatives],
undated
|
| 58 |
3 |
Cat 2 02-10 control for 2 02-10, 1C02-10 [negatives],
undated
|
| 58 |
4 |
Cat 3 02-10 -- fig. 1A [negatives],
undated
|
| 58 |
5 |
Cat 4 02-10 [negatives],
undated
|
| 58 |
6 |
Control for Cat 4 02-10 and 6 C02-10 [negatives],
undated
|
| 58 |
7 |
Cat 5 02-10 -- control 10 C02 5 [negatives],
undated
|
| 58 |
8 |
Cat 6 02-10 [negatives],
undated
|
| 58 |
9 |
Cat 7 02-10 [negatives],
undated
|
| 58 |
10 |
Cat 1 02-100 [negatives],
5/14/1957
|
| 58 |
11 |
Cat 2 02-100 [negatives],
undated
|
| 58 |
12 |
Cat 3 02-100 [negatives],
undated
|
| 58 |
13 |
Cat 5 02-100 [negatives],
undated
|
| 58 |
14 |
Cat 6 02-100 [negatives],
undated
|
| 58 |
15 |
Cat 7 02-100 (control) [negatives],
undated
|
| 58 |
16 |
Cat 8 02-100 [negatives],
undated
|
| 58 |
17 |
Cat 9 02-100 [negatives],
undated
|
| 58 |
18 |
Cat 10 02-100 [negatives],
undated
|
| 58 |
19 |
Cat 1 C02-5 -- used #20 for slide for fed. meet [negatives],
4/15/1957
|
| 58 |
20 |
Cat 2 C02-5 [negatives],
9/26/1956
|
| 58 |
21 |
Cat 3 C02-5 [negatives],
undated
|
| 58 |
22 |
Cat 4 C02-5 [negatives],
undated
|
| 58 |
23 |
Cat 5 C02-5 [negatives],
undated
|
| 58 |
24 |
Cat 5 C02-5 -- film too dark, other film of this cat more acceptable [negatives],
undated
|
| 58 |
25 |
Cat 6 C02-5 [negatives],
undated
|
| 58 |
26 |
Cat 7 C02-5 [negatives],
undated
|
| 58 |
27 |
Cat 8 C02-5 [negatives],
undated
|
| 58 |
28 |
Cat 9 C02-5 [negatives],
undated
|
| 58 |
29 |
Cat 10 C02-5 [negatives],
undated
|
| 58 |
30 |
Cat 11 C02-5 [negatives],
undated
|
| 58 |
31 |
Cat 12 C02-5 [negatives],
undated
|
| 58 |
32 |
Cat 13 C02-5 [negatives],
undated
|
| 58 |
33 |
Cat 14 C02-5 [negatives],
undated
|
| 58 |
34 |
Cat 15 C02-5 [negatives],
undated
|
| 58 |
35 |
Cat 16 C02-5 [negatives],
undated
|
| 58 |
36 |
Cat 17 C02-5 [negatives],
5/14/1957
|
| 58 |
37 |
Cat 1 C02-10 -- film 27 used for England, used film 28 for slide fed meet [negatives],
4/15/1957
|
| 58 |
38 |
Cat 2 C02-10 -- make darkest -- fig 1C [negatives],
undated
|
| 58 |
39 |
Cat 3 C02-10 [negatives],
undated
|
| 58 |
40 |
Cat 4 C02-10 [negatives],
undated
|
| 58 |
41 |
Cat 5 C02-10 -- fig 1B [negatives],
undated
|
| 60 |
123 |
Cat 1 SCL -- unstimulated control (#8 to England) [negatives],
5/8/1956
|
| 60 |
124 |
Cat 2 SCL -- 5' retinal stimulation (#19 and 21 to England) [negatives],
5/8/1956
|
| 60 |
125 |
Cat 3 SCL -- stimulated cat [negatives],
5/11/1956
|
| 60 |
126 |
Cat 4 SCL -- unstimulated cat (#20 to England) [negatives],
5/11/1956
|
| 60 |
127 |
Cat 5 SCL -- stimulated [negatives],
5/24/1956
|
| 60 |
128 |
Cat 6 SCL [negatives],
5/24/1956
|
| 60 |
129 |
Cat 7 SCL -- control [negatives],
7/3/1956
|
| 60 |
130 |
Cat 8 SCL -- 5' retinal stimulation [negatives],
7/3/1956
|
| 60 |
131 |
Cat 9 SCL -- stimulated 10' [negatives],
7/26/1956
|
| 60 |
132 |
Cat 11 SCL -- 10 minutes stimulation [negatives],
7/30/1956
|
| 60 |
133 |
Cat 12 SCL -- 5' retinal stimulation [negatives],
9/11/1956
|
| 60 |
134 |
Cat 13 SCL -- control for 5 stimulation (note: film #24 not used) [negatives],
9/11/1956
|
| 58 |
42 |
Cat 1-SCLN (too dark to use) [negatives],
undated
|
| 58 |
43 |
Cat 3-SCLN [negatives],
undated
|
| 59 |
1 |
Cat 1ON -- stimulated optic nerve [negatives],
1/26/1956
|
| 59 |
2 |
Cat 2ON -- optic nerve crushed [negatives],
1/26/1956
|
| 59 |
3 |
Cat 1P -- pentothal -- #8 to slide [negatives],
12/16/1954
|
| 59 |
4 |
Cat 2 -- pentothal [negatives],
12/23/1954
|
| 59 |
5 |
Cat 3P -- cat 3 pentothal [negatives],
12/30/1954
|
| 59 |
6 |
Cat 4P -- pentothal [negatives],
12/30/1954
|
| 59 |
7 |
Cat 5P -- pentothal cat [negatives],
1/6/1955
|
| 59 |
8 |
Cat 6P -- pentothal cat [negatives],
1/6/1955
|
| 59 |
9 |
Cat 7P -- pentothal [negatives],
1/13/1955
|
| 59 |
10 |
Cat 8P -- pentothal [negatives],
1/13/1955
|
| 59 |
11 |
Cat 11P -- pentothal [negatives],
2/4/1955
|
| 59 |
12 |
Cat 12P -- pentothal [negatives],
2/4/1955
|
| 59 |
13 |
Cat 13P [negatives],
2/7/1955
|
| 59 |
14 |
Cat 14P [negatives],
2/17/1955
|
| 59 |
15 |
Cat 1PS -- film series a" [negatives]",
5/11/1955
|
| 59 |
16 |
Cat 1PS [negatives],
5/11/1955
|
| 59 |
17 |
Cat 2PS -- film series "a" [negatives],
5/11/1955
|
| 59 |
18 |
Cat 2PS [negatives],
5/11/1955
|
| 59 |
19 |
Cat 3PS [negatives],
5/12/1955
|
| 59 |
20 |
Cat 4PS [negatives],
5/12/1955
|
| 59 |
21 |
Cat 5PS -- negative #3 and 6 -- make into slides [negatives],
5/13/1955
|
| 59 |
22 |
Cat 1V (films 23 and 24 out of order) [negatives],
10/20/1955
|
| 59 |
23 |
Cat 2V -- (films 21 and 22 were out of order) [negatives],
10/20/1955
|
| 59 |
24 |
Cat 3V [negatives],
10/24/1955
|
| 59 |
25 |
Cat 4V [negatives],
10/24/1955
|
| 59 |
26 |
Cat 5V [negatives],
10/26/1955
|
| 59 |
27 |
Cat 5V [negatives],
10/26/1955
|
| 59 |
28 |
Cat 6V -- lost tissue section [negatives],
10/26/1955
|
| 59 |
29 |
Cat 7V -- films too light [negatives],
11/16/1955
|
| 59 |
30 |
Cat 7V -- films "A" repeat [negatives],
11/16/1955
|
| 59 |
31 |
Cat 8V [negatives],
11/16/1955
|
| 59 |
32 |
Cat 9V [negatives],
11/17/1955
|
| 59 |
33 |
Cat 10V [negatives],
11/17/1955
|
| 59 |
34 |
Cat 11V [negatives],
11/23/1955
|
| 59 |
35 |
Cat 12V [negatives],
11/23/1955
|
| 59 |
36 |
Cat 1VP -- film 18 not used [negatives],
11/19/1955
|
| 59 |
37 |
Cat 2VP [negatives],
11/19/1955
|
| 59 |
38 |
Cat 3VP -- not stimulated visually [negatives],
11/20/1955
|
| 59 |
39 |
Cat 3VP and Cat 4VP -- visually stimulated [negatives],
11/20/1955
|
| 59 |
40 |
Cat L1(a) [negatives],
7/7/1955
|
| 59 |
41 |
Cat L1 [negatives],
7/7/1955
|
| 59 |
42 |
Cat L2 [negatives],
7/7/1955
|
| 59 |
43 |
Cat L4 [negatives],
7/16/1955
|
| 59 |
44 |
Cat L5 [negatives],
7/12/1955
|
| 59 |
45 |
Cat L6 -- "Lou" [negatives],
undated
|
| 59 |
46 |
Cat L7 [negatives],
7/28/1955
|
| 59 |
47 |
Cat L8 [negatives],
7/28/1955
|
| |
P
[subseries]:
|
| 56 |
170 |
P 107 diazepam vs. control [photographs],
undated
|
| 56 |
171 |
P 108 D and M lesion vs. control [photograph],
undated
|
| 56 |
172 |
P 109 morphine vs. control [photographs],
undated
|
| 56 |
173 |
P 110 LBH lesion vs. control [photographs],
undated
|
| 56 |
174 |
P 163 arumd (Kennedy) [photographs],
undated
|
| 56 |
175 |
P 192 thiopental rat [photographs],
undated
|
| |
SM
[subseries]:
|
| 56 |
176 |
SM-3 [photographs],
undated
|
| 56 |
177 |
SM-6 (both eyes patched) [photographs, negatives],
undated
|
| 56 |
178 |
SM-12 [photographs],
undated
|
| 56 |
179 |
SM-13 left eye enucleation [photograph],
undated
|
| 56 |
180 |
SM-14 [photograph],
undated
|
| 56 |
181 |
SM-21,
undated
|
| 56 |
182 |
SM-21 rt. eye enucleation [photographs, negative],
undated
|
| 56 |
183 |
SM-23 control [photographs, negatives],
undated
|
| 56 |
184 |
SM-25 [photographs],
undated
|
| 56 |
185 |
SM-26 eye patched [photographs, negative],
undated
|
| 56 |
186 |
SM-27 [photographs, negative],
undated
|
| 56 |
187 |
SM-28 long term monocular occlusion [photographs, negative],
undated
|
| 56 |
188 |
SM-29 [photographs, negative],
undated
|
| 56 |
189 |
SM-33 [photographs, negative],
undated
|
| 56 |
190 |
SMII -- both eyes open before rotatory screen [photographs, negatives],
undated
|
| |
Unnumbered,
1954-1988 [subseries]:
|
| 56 |
191 |
Unidentified negatives [photographs, negative],
undated
|
| 60 |
135 |
[unidentified] [negatives],
undated
|
| 60 |
136 |
[unidentified] [negatives],
undated
|
| 56 |
192 |
A/V DG plasma concentration in cat [photographs],
undated
|
| 56 |
193 |
ARC 146A Stds. (OMI film),
1985-1986
|
| 56 |
194 |
Blood flow in anesthetized rats [photographs, negatives],
undated
|
| 136 |
22 |
Buhda Films,
undated
|
| 56 |
195 |
CBF and CMR 02 [photographs, negatives],
undated
|
| 56 |
196 |
CBF and CMR 02 [photographs, negatives],
undated
|
| 56 |
197 |
Circulatory system of the human head [photographs, negative],
undated
|
| 56 |
198 |
Cocaine [photograph],
undated
|
| 56 |
199 |
Crop [photographs, negative],
undated
|
| 60 |
137 |
Densitometric calibration control -- 9 stds [negative],
6/18/1954
|
| 56 |
200 |
Derivation of Patlak plot [photographs],
undated
|
| 56 |
201 |
Effect of morphine on glucose utilization [photographs],
undated
|
| 56 |
202 |
Effective rate constant vs. time [photographs, negative],
undated
|
| 56 |
203 |
Electrophoretic patterns of purified HMBP's [photographs, negatives],
undated
|
| 56 |
204 |
Exposure [negative],
1988
|
| 58 |
44 |
1st attempt to judge if the krypton 85 diffuses out of std with sawing -- too dark, probably not [negatives],
undated
|
| 58 |
45 |
2nd attempt to judge if Kr85 diffuses from head with sawing -- not as can be determined [negatives],
undated
|
| 56 |
205 |
Human central anterior circulation [photographs, negative],
undated
|
| 56 |
206 |
Hypophysis [photographs],
undated
|
| 56 |
207 |
Hypothalamus (insulin effect on LGU) [photographs, slide],
undated
|
| 56 |
208 |
Joke: May be on to something. . ." [negative]",
undated
|
| 56 |
209 |
LCBF [photographs, negatives],
1971
|
| 56 |
210 |
LCBF in mice [photographs, negatives],
undated
|
| 56 |
211 |
LCGU in sup. collic. and lateral geniculate nucleus [photographs, negative],
undated
|
| 56 |
212 |
Lateral surface of the macaque brain [negatives],
undated
|
| 56 |
213 |
Leg blood flow metabolism [photographs, negatives],
undated
|
| 56 |
214 |
Locus coeruleus [photographs],
undated
|
| 56 |
215 |
MEG of rat L + R enucleation -- sup. col. only -- test photos [negatives],
undated
|
| 60 |
138 |
Materials for slides,
undated
|
| 56 |
216 |
Methods fig. [photographs, negatives],
undated
|
| 56 |
217 |
Misc. [negatives],
undated
|
| 56 |
218 |
Model and operational equation for equilibrium method for the determination of local cerebral blood flow,
undated
|
| 56 |
219 |
Monkey not working [photographs],
undated
|
| 56 |
220 |
Monkey put. in Parkinsonism [photographs, negative],
undated
|
| 56 |
221 |
Monkey using lt. arm suppl. motor ctx. [photographs],
undated
|
| 56 |
222 |
Motor cortex [photographs, negative],
undated
|
| 56 |
223 |
Moving lt. arm and inactive [photographs, negative],
undated
|
| 59 |
48 |
Name -- Seymour [negatives],
undated
|
| 59 |
49 |
Name -- Lou [negatives],
undated
|
| 59 |
50 |
Name -- Bill [negatives],
undated
|
| 59 |
51 |
Name -- Bud [negatives],
undated
|
| 59 |
52 |
Name -- Walt [negatives],
undated
|
| 59 |
53 |
Name -- Darob [negatives],
undated
|
| 59 |
54 |
Name -- Mary [negatives],
undated
|
| 59 |
55 |
Name -- Bob [negatives],
undated
|
| 56 |
224 |
Newborn 101, long term patching,
1976-1977
|
| 56 |
225 |
Newborn (NBM 2) eye patched [photographs, negative],
undated
|
| 56 |
226 |
Newborn (NBM 5) control [photographs, negative],
undated
|
| 56 |
227 |
Newborn (NBM-6) control [photographs, negative],
undated
|
| 56 |
228 |
Newborn (NBM-I) control [photographs, negative],
undated
|
| 56 |
229 |
Newborn puppies. antipyrine -- blood flow [photographs],
undated
|
| 56 |
230 |
Nose -- photos [photographs],
undated
|
| 57 |
1 |
Operational equation [photographs],
undated
|
| 57 |
2 |
Parkinsonian syndrome [photographs, negatives],
undated
|
| 57 |
3 |
Percentage dephosphorylation of [14C] DG-6-P at time F [photographs, negatives],
undated
|
| 57 |
4 |
Phosphate [photographs, negative],
undated
|
| 57 |
5 |
Postmortem changes in DG and metabolites [photographs, negative],
undated
|
| 57 |
6 |
Rat -- normal controls -- LCGU [photographs],
undated
|
| 57 |
7 |
Rat auditory structures LCGO,
undated
|
| 57 |
8 |
Rat visual structure LCGU, enucleation [photograph],
undated
|
| 57 |
9 |
Sciatic n. stimu. and DRG [photographs],
undated
|
| 57 |
10 |
Subfornical organ [photograph, slide],
undated
|
| 57 |
11 |
Subfornical organ vs. saline, A 11 and saralasin A11 [photograph],
undated
|
| 57 |
12 |
Sugar [photographs],
undated
|
| 57 |
13 |
T 86 changes in metabolic activity following stimu. of the ventral,
undated
|
| 136 |
23 |
Tattoo Films,
undated
|
| 57 |
14 |
Thiomin section -- rat spinal cord [photographs],
undated
|
| 57 |
15 |
Windy -- photos [photographs, negative],
undated
|
| 57 |
16 |
Wortz geometric design [photographs],
undated
|
| 58 |
46 |
X-sympathetic stim. [negatives],
undated
|
| |
Autoradiographs,
1970-2002 [subseries]:
|
| 61 |
|
Standards C14, Cold Brain, Puppy Lambda, Equilibrium study [48 autoradiographs],
1970-1985
|
| 61 |
|
Cat-1 and Cat-3 [19 autoradiographs],
1971
|
| 61 |
|
CBF Cat-1 through CBF Cat-6 [38 autoradiographs],
1971
|
| 61 |
|
EC-1 [1 autoradiograph],
1971
|
| 61 |
|
Rat X-2 [1 autoradiograph,
1971
|
| 61 |
|
C-1 through C-2 [3 autoradiographs],
1973
|
| 61 |
|
DG-101 through DG-122; HR-201 [29 autoradiographs],
1973, 1976
|
| 61 |
|
DG-201A through DG-216A -- experiment documentation,
1973
|
| 61 |
|
DG-201A through DG-216A [19 autoradiographs],
1973
|
| 61 |
|
DGH3-test and DGH3-1 [4 autoradiographs],
1973
|
| 61 |
|
MG-5-6, 8-9, 12, 14-16 [8 autoradiographs],
1973
|
| 61 |
|
MG-101 through MG-114 [14 autoradiographs],
1973
|
| 61 |
|
MG-1-4, 7, 10, 13, 17, 18; Methyl glucose 10 minutes [10 autoradiographs],
1973, 1977
|
| 61 |
|
SC1 and SC1A [23 autoradiographs],
1973
|
| 61 |
|
SM-2 [stimulated squirrel monkey] [23 autoradiographs],
1973
|
| 61 |
|
SM-2A [stimulated squirrel monkey] [10 autoradiographs],
1973
|
| 61 |
|
SM-3 [stimulated rhesus monkey] [11 autoradiographs],
1973
|
| 61 |
|
SM-4A [stimulated monkey] [18 autoradiographs],
1973
|
| 62 |
|
SR-1 through SR-5 [visual experiment]; SSR-1 through SSR-4 [sciatic nerve stimuli]; AUD-test and 2 through AUD-4 [auditory experiment] [24 autoradiographs],
1973-1974
|
| 62 |
|
ARF-1 through ARF-16 [CBF antiyprene] [18 autoradiographs],
1974
|
| 62 |
|
Monkey and rat intestines [1 radiograph],
1974
|
| 62 |
|
SM-3A [stimulated rhesus monkey] [19 autoradiographs],
1974
|
| 62 |
|
SM-5 [stimulated rhesus monkey] [16 autoradiographs],
1974
|
| 62 |
|
SM-6 [stimulated rhesus monkey] -- experiment documentation,
1974
|
| 62 |
|
SM-6 [stimulated rhesus monkey] [28 autoradiographs],
1974
|
| 62 |
|
SM-7 [stimulated monkey] [5 autoradiographs],
1974
|
| 62 |
|
SM-8A [stimulated rhesus monkey] [13 autoradiographs],
1974
|
| 62 |
|
SM-9A [stimulated rhesus monkey] [11 autoradiographs],
1974
|
| 62 |
|
SM-10 [stimulated monkey] [21 autoradiographs],
1974
|
| 62 |
|
SM-11 [stimulated rhesus monkey] [13 autoradiographs],
1974
|
| 62 |
|
SM-12 [stimulated rhesus monkey] [13 autoradiographs],
1974
|
| 62 |
|
SM-13 [stimulated rhesus monkey] [26 autoradiographs],
1974
|
| 62 |
|
AR-1 through AR-13 [anesthesia studies] [16 autoradiographs],
1974-1975
|
| 63 |
|
CR-1-5, 101-105; CB-4-7, 9; CRF-201; C02 5 percent [22 autoradiographs],
1974-1976
|
| 63 |
|
CRF-2-15, 101-105, 111-115 [33 autoradiographs],
1974-1975
|
| 63 |
|
FD1 [1 radiograph],
1975
|
| 63 |
|
GBL-12 through GBL-15 [4 autoradiographs],
1975
|
| 63 |
|
GL1 Cat [8 autoradiographs],
1975
|
| 63 |
|
MTZ-2 [2 autoradiographs],
1975
|
| 63 |
|
PEN-1 through PEN-3 [penicillin seizure studies] [3 autoradiographs],
1975
|
| 63 |
|
Pen Cat-1 [8 autoradiographs],
1975
|
| 63 |
|
SLC-1 through SLC-2 [15 autoradiographs],
1975
|
| 63 |
|
SM-14 [stimulated rhesus monkey] [16 autoradiographs],
1975
|
| 63 |
|
SM-15 [stimulated rhesus monkey] [22 autoradiographs],
1975
|
| 63 |
|
SM-16 [stimulated rhesus monkey] [32 autoradiographs],
1975
|
| 63 |
|
SM-17 [stimulated rhesus monkey] [29 autoradiographs],
1975
|
| 63 |
|
SM-18 [stimulated rhesus monkey] [23 autoradiographs],
1975
|
| 64 |
|
SM-19 [stimulated rhesus monkey] [19 autoradiographs],
1975
|
| 64 |
|
SM-20 [stimulated rhesus monkey] [16 autoradiographs],
1975
|
| 64 |
|
SM-21 [stimulated rhesus monkey] [20 autoradiographs],
1975
|
| 64 |
|
SM-22 [stimulated rhesus monkey] [22 autoradiographs],
1975
|
| 64 |
|
WB-6-10, 13, 19 [13 autoradiographs],
1975
|
| 64 |
|
KSA-101-102, 104-111; KSH-1 through KSH-10; KSM-101 through KSM-102 [Kety-Schmitt assay] [16 autoradiographs],
1975-1976
|
| 64 |
|
LSD-DG-1-4, 1-13, 101-105, 151-153, 201-205, 301-305, 301-303, 401-407, 501-504, 601-603, 701 [57 autoradiographs],
1975-1976
|
| 64 |
|
MR, MA, MN, NAL, OIL -- experiment documentation,
1975-1976
|
| 64 |
|
MR-1-8, 101-104, 202-204; MA-2 through MA-6; MN-1 through MN-6; NAL-1 through NAL-6; OIL-1 through OIL-2 [morphine active chronic -- naloxone] [45 autoradiographs],
1975-1976
|
| 65 |
|
REM Cat-1 through REM Cat-3 [23 autoradiographs],
1975-1976
|
| 65 |
|
End-1 through End-12 [endorphins] [12 autoradiographs],
1976
|
| 65 |
|
End NC-1 through End NC-6 [6 autoradiographs],
1976
|
| 65 |
|
IOD Cat-1 through IOD Cat-2 [7 autoradiographs],
1976
|
| 65 |
|
IOD Cat-1 through IOD Cat-2 [8 autoradiographs],
1976
|
| 65 |
|
IOD Cat-3 [9 autoradiographs],
1976
|
| 65 |
|
IOD Cat-4 [6 autoradiographs],
1976
|
| 65 |
|
IOD Cat-5 [9 autoradiographs],
1976
|
| 65 |
|
IOD Cat-6 [8 autoradiographs],
1976
|
| 65 |
|
IOD Cat-7 [7 autoradiographs],
1976
|
| 65 |
|
IOD gamma-1 through IOD gamma-13; cold brain [15 autoradiographs],
1976
|
| 65 |
|
IODO-1 through IODO-6; Antipyrine-1 through Antipyrine-6 and trial [13 autoradiographs],
1976
|
| 65 |
|
NBM-1 [new born monkey] [18 autoradiographs],
1976
|
| 65 |
|
NBM-2 [new born monkey] [16 autoradiographs],
1976
|
| 65 |
|
NBM-3 [new born monkey] [15 autoradiographs],
1976
|
| 65 |
|
NBM-4 [new born monkey] [15 autoradiographs],
1976
|
| 65 |
|
NBM-5 [new born monkey] [16 autoradiographs],
1976
|
| 65 |
|
NBM-6 [new born monkey] [17 autoradiographs],
1976
|
| 65 |
|
NBM-7 [new born monkey] [17 autoradiographs],
1976
|
| 65 |
|
NBM-8 [new born monkey] [17 autoradiographs],
1976
|
| 65 |
|
NBM-101 [new born monkey] [22 autoradiographs],
1976
|
| 66 |
|
Piridine#1 [1 radiograph],
1976
|
| 66 |
|
REM Cat-4 and SLC-6 [11 autoradiographs],
1976
|
| 66 |
|
REM Cat-5 -- experiment documentation,
1976
|
| 66 |
|
REM Cat-5 [7 autoradiographs],
1976
|
| 66 |
|
SM-23 [stimulated rhesus monkey] [18 autoradiographs],
1976
|
| 66 |
|
SM-24 [stimulated rhesus monkey] -- experiment documentation,
1976
|
| 66 |
|
SM-24 [stimulated rhesus monkey] [14 autoradiographs],
1976
|
| 66 |
|
SM-25 [stimulated rhesus monkey] [15 autoradiographs],
1976
|
| 66 |
|
SM-27 [stimulated rhesus monkey] [21 autoradiographs],
1976
|
| 66 |
|
SM-28 [stimulated rhesus monkey] [31 autoradiographs],
1976
|
| 66 |
|
SM-29 [stimulated monkey] [24 autoradiographs],
1976
|
| 66 |
|
SM-30 [stimulated monkey] [23 autoradiographs],
1976
|
| 66 |
|
ADR-1 through ADR-12; PRP-0 through PRP-13; PH-0 through PH-14; L-ALP-3 through L-ALP-6; CSPE-1 through CSPE-4; PPE-1 through PPE-6; PRP and PH-1; SOT-1 through SOT-3; D-PRP-0 through D-PRP-4; L-PRP-0 through L-PRP-4 [74 autoradiographs],
1976-1977
|
| 66 |
|
D-AMP-1-8, 101, 103-109; L-AMP-1-7, 101-105; HLNC-1 through HLNC-15 [42 autoradiographs],
1976-1977
|
| 67 |
|
CS-1 through CS-27; D-1; CSO-2; C-DEX-1; DEX-1 through DEX-4 [control saline] [43 autoradiographs],
1976-1979
|
| 67 |
|
CS, YOH, DEX, PH, D-AMP, PX -- experiment documentation,
1976-1979
|
| 67 |
|
CS-23; YOH-1 and 14; DEX-5; PH-2 and 6; D-AMP-102; PX-12, 14, 16, 21 [20 autoradiographs],
1976-1979
|
| 67 |
|
DG-136, 148, 167-168, 172, 174-181, 187-189; Tail-1 through Tail-6 [41 autoradiographs],
1976-1978
|
| 67 |
|
DG-124-135, 137-138, 142-145, 149-151, 154-158, 163, 165-166, 171, 173; PH9; FRD-3 [38 autoradiographs],
1976-1978
|
| 67 |
|
AR-1 through AR-6, AR-8 [aged rats] [10 autoradiographs],
1977
|
| 67 |
|
Cat-101 through Cat-105 [39 autoradiographs],
1977
|
| 67 |
|
CBS-4 through CBS-6; CS-1 through CS-2 [8 autoradiographs],
1977
|
| 67 |
|
DGX; DG [58 autoradiographs],
1977
|
| 67 |
|
Fetal sheep -- experiment documentation,
1977
|
| 67 |
|
Fetal sheep-1 through 6, and 8-13 [14 autoradiographs],
1977
|
| 68 |
|
Fetal sheep-3 -- experiment documentation,
1977
|
| 68 |
|
Fetal sheep-3 [10 autoradiographs],
1977
|
| 68 |
|
Free moving-1 [free moving vs. N20 bag rats] [1 radiograph],
1977
|
| 68 |
|
Free moving-1 through Free moving-9; N20 bag-1 through N20 bag-8 [free moving vs. N20 bag rats] [26 autoradiographs],
1977
|
| 68 |
|
HIG-1 through HIG-5 [normal control] [10 autoradiographs],
1977
|
| 68 |
|
IOD Cat-8 [7 autoradiographs],
1977
|
| 68 |
|
NC-1 through NC-6 [6 autoradiographs],
1977
|
| 68 |
|
NO-1 through NO-6; NOF-1 through NOF-6; Free moving-1 through Free moving-8 [nitrous oxide/free moving] [20 autoradiographs],
1977
|
| 68 |
|
One ear rat [3 autoradiographs],
1977
|
| 68 |
|
RBAA-18(test) [1 radiograph],
1977
|
| 68 |
|
RTAA1 [2 autoradiographs],
1977
|
| 68 |
|
SCD-KCL-1 through SCD-KCL-17; SCD-5; SCD-0-1, 2, 3, and 5; SCD-NACL-1; SCD-OK-1 through SCD-OK-15; SCD-OKF-1; SCD-F-1 through SCD-F-8 [spreading cortical depression] [50 autoradiographs],
1977
|
| 68 |
|
SM-31 [stimulated rhesus monkey] [20 autoradiographs],
1977
|
| 68 |
|
SM-32 [stimulated monkey] [22 autoradiographs],
1977
|
| 68 |
|
SM-33 [stimulated rhesus monkey] [16autoradiographs],
1977
|
| 68 |
|
SSM-1 [18 autoradiographs],
1977
|
| 68 |
|
SSM-2 [26 autoradiographs],
1977
|
| 68 |
|
SSM-3 [17 autoradiographs],
1977
|
| 68 |
|
SSM-4 [18 autoradiographs],
1977
|
| 69 |
|
ABS-1 through ABS-4; 1856-5 through 1856-8; Toxin-1, 12-14 [24 autoradiographs],
1977-1978
|
| 69 |
|
ARC-1 through ARC-8 -- experiment documentation,
1977-1978
|
| 69 |
|
ARC-1 through ARC-8 [14 autoradiographs],
1977-1978
|
| 69 |
|
GS-1 through GS-17 [gastric secretion] [51 autoradiographs],
1977-1978
|
| 69 |
|
Harvard rat-1-7, 10, 13-17 [36 autoradiographs],
1977, 1979
|
| 69 |
|
MIK-1, 2, 5, 9-10; MAK-1, 6, 8-13; B-1, 2, 5, 7-9, 11-15 [44 autoradiographs],
1977-1978
|
| 69 |
|
SCD-20-1 and SCD-20-2; SCD-40-1 and SCD-40-2; SCD-M-1 through SCD-M-3; SCD-80-1; SCD-150-1 [spreading cortical depression] [22 autoradiographs],
1977-1978
|
| 69 |
|
DEX-1 through DEX-5; DEXT-PX-1 through DEXT-PK-5; Ph-8 [dextran] [31 autoradiographs],
1977-1979
|
| 70 |
|
A-9 [2 autoradiographs],
1978
|
| 70 |
|
ACL-1, 3, and 4; BCL-1 through BCL-4 [albino/pigmented rats continuous intense light exposure] [14 autoradiographs],
1978
|
| 70 |
|
ADVS-1 through ADVS-4; BDVS-1 through BDVS-4 [16 autoradiographs],
1978
|
| 70 |
|
AE, BE, ABE, BBE [albino/pigmented enucleation studies] -- experiment documentation,
1978
|
| 70 |
|
AE-1 through AE-5; BE-1 through BE-5; ABE-1; BBE-1 [40 autoradiographs],
1978
|
| 70 |
|
Airbag-1 through Airbag-9 [air bag #8 normal control] [19 autoradiographs],
1978
|
| 70 |
|
AVS, BVS, ADR, MAK-TI, MAK-II -- experiment documentation,
1978
|
| 70 |
|
AVS-0-1 through AVS-0-4, AVS-0-11 through AVS-0-14; BVS-0-1 through BVS-0-7; ADR-1 and ADR-11; MAK-TI-1 through MAK-TI-2; MAK-II-2 [45 autoradiographs],
1978
|
| 70 |
|
Cat Cord 1 (spinal cord and brain) [17 autoradiographs],
1978
|
| 70 |
|
CL-CT-1 [3 autoradiographs],
1978
|
| 70 |
|
Dee [36 autoradiographs],
1978
|
| 70 |
|
DG-182-186, 190-196, 198-199 [28 autoradiographs],
1978
|
| 71 |
|
Fetal sheep 221 [21 autoradiographs],
1978
|
| 71 |
|
Fetal sheep 228 -- experiment documentation,
1978
|
| 71 |
|
Fetal sheep 228 [15 autoradiographs],
1978
|
| 71 |
|
Fetal sheep 244 -- experiment documentation,
1978
|
| 71 |
|
Fetal sheep 244 [16 autoradiographs],
1978
|
| 71 |
|
GRC-10B [1 radiograph],
1978
|
| 71 |
|
GS-19-20, 22-33, 36-45 [gastric secretion] [75 autoradiographs],
1978
|
| 71 |
|
GS-27and GS-38 [2 autoradiographs],
1978
|
| 71 |
|
Lamb-1 through Lamb-2 [11 autoradiographs],
1978
|
| 71 |
|
MG-64 [2 autoradiographs],
1978
|
| 71 |
|
MSG-1 through MSG-7 [21 autoradiographs],
1978
|
| 72 |
|
MSG-6 [2 autoradiographs],
1978
|
| 72 |
|
NaCl-1 through NaCl-9; MSB-2, 4, 5; DG-170 [saline group] [34 autoradiographs],
1978
|
| 72 |
|
Phosphate-1 through Phosphate-32 [33 autoradiographs],
1978
|
| 72 |
|
Rocky-1 through Rocky-32 [stimulated monkey] [38 autoradiographs],
1978
|
| 72 |
|
SCD-80-1 through SCD-80-4; SCD-80-6 through SCD-80-10 [spreading cortical depression] [18 autoradiographs],
1978
|
| 72 |
|
SCD-V-1-0; SCD-V-1 through SCD-V-10; SCD-90-11; SCD-OK-21 through SCD-OK-22 [spreading cortical depression] [28 autoradiographs],
1978
|
| 72 |
|
Space Cat-A and Space Cat-B [2 autoradiographs],
1978
|
| 72 |
|
Stand VS-S-1 and Stand VS-3 [3 autoradiographs],
1978
|
| 72 |
|
Windy [33 autoradiographs],
1978
|
| 72 |
|
YOH-3-7, 10-13 [27 autoradiographs],
1978
|
| 72 |
|
Zieg-C [2 autoradiographs],
1978
|
| 72 |
|
ANL-1 through ANL-4; BNL-1 through BNL-4; AVS-1-4, 21-24, 31-34, 41-44; BVS-1-4, 21-24, 31-34, 41-44, 51-54 [85 autoradiographs],
1978-1979
|
| 73 |
|
APO-7, 13 -- experiment documentation,
1978-1979
|
| 73 |
|
APO-7, 13 [31 autoradiographs],
1978-1979
|
| 73 |
|
APO-18-1 through APO-18-7; APO-C through APO-3C -- experiment documentation,
1978-1979
|
| 73 |
|
APO-18-1 through APO-18-7; APO-C through APO-3C [38 autoradiographs],
1978-1979
|
| 73 |
|
DG-200-205, 207-217; CK-1 through CK-2 [43 autoradiographs],
1978-1979
|
| 73 |
|
SCG -- experiment documentation,
1978-1979
|
| 73 |
|
BDSCG-1 and BDSCG-2; BSDSCG-1 and BSDSCG-2; BD2SCG-1 and BD2SCG-2; BD3SCG-1 and BD3SCG-2 [8 autoradiographs],
1978-1979
|
| 73 |
|
IHG-1 through IHG-8 [17 autoradiographs],
1978-1979
|
| 73 |
|
LIDO-1 through LIDO-13 [Lidocaine] [31 autoradiographs],
1978-1979
|
| 74 |
|
LIDO-1, 2, 5-13 [Lidocaine] [24 autoradiographs],
1978-1979
|
| 74 |
|
PX-0-9, 13-20, 22 [phenoxybenzomine] [52 autoradiographs],
1978-1979
|
| 74 |
|
SHR-4 [1 autoradiograph],
1978-1979
|
| 74 |
|
YOH-14 through YOH-29 [47 autoradiographs],
1978-1979
|
| 74 |
|
APO-4-1 through APO-4-12 -- experiment documentation,
1979
|
| 74 |
|
APO-4-1 through APO-4-12 [33 autoradiographs],
1979
|
| 74 |
|
APO-28-1 through APO-28-6 -- experiment documentation,
1979
|
| 74 |
|
APO-28-1 through APO-28-6 [27 autoradiographs],
1979
|
| 74 |
|
Cat- experiment documentation [2 folders],
1979
|
| 75 |
|
Cold brain w/ hot holes -- experiment documentation,
1979
|
| 75 |
|
Cold brain w/ hot holes -1 and 2 [7 autoradiographs],
1979
|
| 75 |
|
DG-206, 216-217 [16 autoradiographs],
1979
|
| 75 |
|
DX-1 [glycerol perfused brain] [1 radiograph],
1979
|
| 75 |
|
GC-1 [2 autoradiographs],
1979
|
| 75 |
|
Gee [32 autoradiographs],
1979
|
| 75 |
|
Harvard sleep rat-1 through Harvard sleep rat-4 [16 autoradiographs],
1979
|
| 75 |
|
HY, HYP, HY-CONT, HYR -- experiment documentation [hypoxia (pigmented rats)],
1979
|
| 75 |
|
HY-1-6, 20-21, 601; HYP-1 through HYP-4; HY-7-9, 10-12, 21-26; HY-CONT-2-4, 6, 7; HYR-1 through HYR-2 [95 autoradiographs],
1979
|
| 76 |
|
HY-7 [1 radiograph],
1979
|
| 76 |
|
HY-cont-5 -- experiment documentation,
1979
|
| 76 |
|
HY-cont-5 [3 autoradiographs],
1979
|
| 76 |
|
KK-1 [1 radiograph],
1979
|
| 76 |
|
Milt-1 through Milt-32 [32 autoradiographs],
1979
|
| 76 |
|
PCP-2 [2 autoradiographs],
1979
|
| 76 |
|
Reza [25 autoradiographs],
1979
|
| 76 |
|
Sugar-1 through Sugar-29 [30 autoradiographs],
1979
|
| 76 |
|
TOE-1 [toe stimulation] [6 autoradiographs],
1979
|
| 76 |
|
Acid -- experiment documentation (23, 32),
1979-1980
|
| 76 |
|
Acid-1, 6-9, 16, 20, 22-26, 32-41; NOR-4 through NOR-5; Heart-10 through Heart-12 and Heart-18; CHO-13 [68 autoradiographs],
1979-1980
|
| 76 |
|
Landau [24 autoradiographs],
1979-1980
|
| 76 |
|
SCG -- 1A5 through 4A5; 2A10 through 4A10; CA15; 1A15, 3A15, 4A15; 1A20 through 4A20 [15 autoradiographs],
1979-1980
|
| 77 |
|
Amanda -- experiment documentation,
1980
|
| 77 |
|
Amanda; Amanda eyes; Amanda spinal cord [31autoradiographs],
1980
|
| 77 |
|
Atlas-1 [3 autoradiographs],
1980
|
| 77 |
|
BSL-1 and BSL-3 [2 autoradiographs],
1980
|
| 77 |
|
Cat 201 [8 autoradiographs],
1980
|
| 77 |
|
Cat 202 [10 autoradiographs],
1980
|
| 77 |
|
Cat 203 [10 autoradiographs],
1980
|
| 77 |
|
CSN-12 [17 autoradiographs],
1980
|
| 77 |
|
Dreamless -- experiment documentation (3-6, 19-24),
1980
|
| 77 |
|
Dreamless -test, 2-29 [29 autoradiographs],
1980
|
| 77 |
|
Marley [37 autoradiographs],
1980
|
| 77 |
|
N2O-2 and N2O-4 [2 autoradiographs],
1980
|
| 77 |
|
OLF -- experiment documentation,
1980
|
| 77 |
|
OLF-1 through OLF-2 [4 autoradiographs],
1980
|
| 77 |
|
Posh -- experiment documentation (7-10, 13-15, 19-24),
1980
|
| 77 |
|
Posh -test, 1-10, 13-26 [26 autoradiographs],
1980
|
| 77 |
|
PRT-2 through PRT-4 [12 autoradiographs],
1980
|
| 78 |
|
Retina-1 through Retina-3 -- experiment documentation,
1980
|
| 78 |
|
Retina-1 through Retina-3 [11 autoradiographs],
1980
|
| 78 |
|
Valium diazepam -- experiment documentation [i.e. VALC, VALL, VALIUM, VAM, VALM],
1980
|
| 78 |
|
VALC-1 through VALC-8; VALL-1 through VALL-6; VALIUM-1, 2, 4 through 6; VAM-1 through VAM-6; VALM-3 and VALM-7 [70 autoradiographs],
1980
|
| 78 |
|
SCG-63, 65-66, 74, 76, 78, 80, 83, 101, 131; and CONT-1 and 2 [34 autoradiographs],
1980, 1983
|
| 78 |
|
HBC, LHB -- experiment documentation,
1980-1981
|
| 78 |
|
HBC-1 through HBC-4; LHB-1, 3-8 [unilateral lesion of habenula] [31 autoradiographs],
1980-1981
|
| 78 |
|
HG-1-3, 5-6, 8-9, 12-15; LCGU-73; HPYGL-3; Hyper-74 [48 autoradiographs],
1980-1982
|
| 78 |
|
HG; HG-SCG; HG-Pit; HG-Ganglia; HGC; CO; Hyper -- experiment documentation,
1980-1983
|
| 78 |
|
HG-3-10, 12-15; HG-SCG-27-32; HG-Pit-1-33; HG-ganglia-2, 3, 5, 6, 9-10, 12-15, 21-26; HGC-1-3; CO-1-2; Hyper-4-5 [73 autoradiographs],
1980-1983
|
| 78 |
|
MRC, MRH, MRM, MC, Morph, M10 -- experiment documentation,
1980-1981
|
| 79 |
|
MRC-1 through MRC-2; MRH-1 through MRH-9; MRM-1 through MRM-6; MC-6; Morph cont-1 through Morph cont-5; Morph-1 through Morph-8; M10-1 through M10-6 [morphine low dose saline] [96 autoradiographs],
1980-1981
|
| 79 |
|
Rat 85c and 87b [5 autoradiographs],
1980-1981
|
| 79 |
|
Rat 812b through Rat 829 [26 autoradiographs],
1980-1981
|
| 79 |
|
Sleep control -- spinal cord-(various) [12 autoradiographs],
1980-1981
|
| 79 |
|
AC-1 through AC-5 [17 autoradiographs],
1981
|
| 79 |
|
AL-1 through AL-6 [23 autoradiographs],
1981
|
| 79 |
|
Blue; Bube-test [46 autoradiographs],
1981
|
| 79 |
|
Cat 729 through Cat 730 [18 autoradiographs],
1981
|
| 80 |
|
Chili-test, 1-31, 33-39 [39 autoradiographs],
1981
|
| 80 |
|
Fen Con-1-2, 4-5 -- experiment documentation,
1981
|
| 80 |
|
Fen Con-1-2, 4-5 [18 autoradiographs],
1981
|
| 81 |
|
Fetal sheep 178 -- experiment documentation,
1981
|
| 81 |
|
Fetal sheep 178 -- test, 1-16 [25 autoradiographs],
1981
|
| 81 |
|
Fetal sheep 181 -- experiment documentation,
1981
|
| 81 |
|
Fetal sheep 181 -test, 1-14 [18 autoradiographs],
1981
|
| 81 |
|
Fredrik, Hans, Inge [20 autoradiographs],
1981
|
| 81 |
|
Isabella-1 through Isabella-8 (plus others) [19 autoradiographs],
1981
|
| 81 |
|
Ketacat [14 autoradiographs],
1981
|
| 81 |
|
RC-1-3, 5-15, 17-23; RC heart-6-15, 17-21 [36 autoradiographs],
1981
|
| 81 |
|
RC-500 through RC-514 [32 autoradiographs],
1981
|
| 81 |
|
Toast-test, 1-27, 28-42 [sleep lps before fixation] [44 autoradiographs],
1981
|
| 82 |
|
A -- experiment documentation,
1981-1983
|
| 82 |
|
A-101-111, 113-116, 118-122, 125-126s, 132-134, 136-137 [75 autoradiographs],
1981-1983
|
| 82 |
|
AGE M-1 through AGE-M-5; AGE MC-1 through AGE-MC-6 -- experiment documentation,
1981-1982
|
| 82 |
|
AGE M-1 through AGE-M-5; AGE MC-1 through AGE-MC-6 [36 autoradiographs],
1981-1982
|
| 82 |
|
ASP; ASP Fixed [66 autoradiographs],
1981-1982
|
| 82 |
|
Fetal sheep 163 -- experiment documentation,
1981-1982
|
| 82 |
|
Fetal sheep 163-1 through Fetal sheep 163-14 [14 autoradiographs],
1981-1982
|
| 82 |
|
Fetal sheep 163 -- experiment documentation,
1981-1982
|
| 82 |
|
Fetal sheep 163-test, 5-12, 14 [13 autoradiographs],
1981-1982
|
| 83 |
|
SCG [sham operation under urethane] -- experiment documentation,
1981-1983
|
| 83 |
|
SCG-37, 75-77, 79, 84-86, 102-110, 113-117 [sham operation under urethane] [65 autoradiographs],
1981-1983
|
| 83 |
|
AN-1 through AN-12 -- experiment documentation,
1982
|
| 83 |
|
AN-1 through AN-12 [36 autoradiographs],
1982
|
| 83 |
|
AP-1 through AP-33 [38 autoradiographs],
1982
|
| 83 |
|
AP-ganglion-16-17, 24-26; AP-pituitary-1-4, 6-7, 9, 11-12, 16-17, 22-26, 28-29, 31 [17 autoradiographs],
1982
|
| 83 |
|
Chicle 1-10, 14, 16-17, 19, 22, 25-29, 32, 34-35, 37-38, 40, 46, 49-57, 59-62 [41 autoradiographs],
1982
|
| 83 |
|
Chicle 11-13, 15, 18, 20-21, 23-24, 30-31, 33, 36, 39, 41-43, 45, 47, 58 [20 autoradiographs],
1982
|
| 84 |
|
DG-81-1 -- experiment documentation,
1982
|
| 84 |
|
DG-81-1 [34 autoradiographs],
1982
|
| 84 |
|
DG-81-2 [31 autoradiographs],
1982
|
| 84 |
|
DG-81-3 -- experiment documentation,
1982
|
| 84 |
|
DG-81-3 -- [28 autoradiographs],
1982
|
| 84 |
|
Egad -- experiment documentation,
1982
|
| 84 |
|
Egad [15 autoradiographs],
1982
|
| 84 |
|
Egad-1-3, 5-7, 16, 22-24, 26-27 [13 autoradiographs],
1982
|
| 84 |
|
Fetal sheep 161 -- experiment documentation,
1982
|
| 84 |
|
Fetal sheep 161 [28 autoradiographs],
1982
|
| 84 |
|
Fetus 164 -- experiment documentation,
1982
|
| 84 |
|
Fetus 164 [9 autoradiographs],
1982
|
| 84 |
|
Fetal sheep 169 -- experiment documentation,
1982
|
| 85 |
|
Fetal sheep 169 [25 autoradiographs],
1982
|
| 85 |
|
Helix 1-8, 10-14, 17-30 [33 autoradiographs],
1982
|
| 85 |
|
Helix 9, 14-16, 19, 21-22, 24-25, 27-30, 38-39, 42-43, 45, 55 [18 autoradiographs],
1982
|
| 85 |
|
Helix 20, 32, 44, 48 [4 autoradiographs],
1982
|
| 85 |
|
Helix 29, 31-37, 40, 44, 46-54, 56-57; Leana test [22 autoradiographs],
1988
|
| 85 |
|
Hokfelt [no numbering] [18 autoradiographs],
1982
|
| 85 |
|
LE-11 and LE-13 [6 autoradiographs],
1982
|
| 85 |
|
PC-1 through PC-14 [43 autoradiographs],
1982
|
| 85 |
|
RC-401 through RC-416 -experiment documentation,
1982
|
| 85 |
|
RC-401 through RC-416 [22 autoradiographs],
1982
|
| 85 |
|
Rony-test, 1-29, 31-35 [36 autoradiographs],
1982
|
| 86 |
|
Toast [27 autoradiographs],
1982
|
| 86 |
|
AMP-1 through AMP-13; LP-4 [40 autoradiographs],
1982-1984
|
| 86 |
|
BHLB and HBC -- experiment documentation,
1982-1983
|
| 86 |
|
BHLB-1 through BHLB-13; HBC-5 through HBC-9 [bilateral lesion of leiteral habenula] [54 autoradiographs],
1982-1983
|
| 86 |
|
DI-4 and DI-18 [4 autoradiographs],
1982-1983
|
| 86 |
|
LHRH-1 through LHRH-26 [84 autoradiographs],
1982-1983
|
| 86 |
|
LHRH Pituitary -- experiment documentation,
1982-1983
|
| 86 |
|
LHRH pit-1 through LHRH pit-26 [11 autoradiographs],
1982-1983
|
| 87 |
|
CAF-1 through CAF-23; JOB-1 [caffeine 1] [88 autoradiographs],
1983
|
| 87 |
|
CAF pit-1-2, 5-7, 9-20; CAF ganglion-1-2, 5-7, 9-20; CAF pit and ganglion-4, 8, 21-23 [caffeine 1] [19 autoradiographs],
1983
|
| 87 |
|
CCK-1-7, 9, 21-26 -- experiment documentation,
1983
|
| 87 |
|
CCK-1-7, 9, 21-26 [41 autoradiographs],
1983
|
| 87 |
|
CCK-pit-1-7, 9-11, 21-24 [8 autoradiographs],
1983
|
| 87 |
|
HG-21-23, 25-33 [36 autoradiographs],
1983
|
| 87 |
|
ISMA 8-45, 47-59 [63 autoradiographs],
1983
|
| 88 |
|
Kazoo [41 autoradiographs],
1983
|
| 88 |
|
Kazoo -- experiment documentation,
1983
|
| 88 |
|
Kazoo [17 autoradiographs],
1983
|
| 88 |
|
Percy 1-11, 15, 18, 20, 22-29, 33-34, 36-38, 40, 42-43, 45, 47-55, 57-61 [47 autoradiographs],
1983
|
| 88 |
|
Percy 12-14, 16-17, 19, 21, 30-32, 35, 39, 41, 44, 46, 56 [16 autoradiographs],
1983
|
| 88 |
|
Pez 1-8, 10-14, 17, 22, 24, 28, 30, 32, 35, 38, 40 43-44, 47-55, 57-62 [40 autoradiographs],
1983
|
| 88 |
|
Pez 9, 15-16, 18-21, 23, 25-27, 29, 31, 33-34, 36-37, 39, 41-42, 45-46, 56 [23 autoradiographs],
1983
|
| 88 |
|
Piggie-1 through Piggie-2 [6 autoradiographs],
1983
|
| 88 |
|
RD, RD-PIT, RAD, RCA -- experiment documentation,
1983
|
| 88 |
|
RD-1, 4, 7, 10, 12, 13; RD-PIT-1, 2, 4, 5, 9, 10, 13; RAD-1, 2, 8, 10, 19, 20; RCA-1 through RCA-3 [radiation] [45 autoradiographs],
1983
|
| 89 |
|
RD-5, 7, and 9 [radiation] [9 autoradiographs],
1983
|
| 89 |
|
Sandro-1-3, 5-7, 9-12, 15-19, 101-109, 112-117, 301-302, 304-316 [57 autoradiographs],
1983
|
| 89 |
|
Sheep fetus 126 [11 autoradiographs],
1983
|
| 89 |
|
SOL BERL-test 1 and 2 [5 autoradiographs],
1983
|
| 89 |
|
Sparky-test, 1-36 [37 autoradiographs],
1983
|
| 89 |
|
Taro-101-103, 105-108, 112-119, 201-216 [32 autoradiographs],
1983
|
| 89 |
|
SCG-119 and SCG-120, with draft of Alterations of local cerebral glucose utilization during chronic dehydration in rats [2 autoradiographs],
1983-1984
|
| 89 |
|
Stick-test, 14; ISMA-46 [3 autoradiographs],
1983, 1988
|
| 90 |
|
CBF Isch-1, 3-7; BF-1 through BF-3 [47 autoradiographs],
1984
|
| 90 |
|
HPG-1 through HPG-11 [49 autoradiographs],
1984
|
| 90 |
|
RK-450 [15 autoradiographs],
1984
|
| 90 |
|
VAG-1 through VAG-2 [6 autoradiographs],
1984
|
| 90 |
|
Woody 10, 34-36, 38, 41-43, 46-47, 49, 51, 53, 55-60, 62-64, 67, 78 [24 autoradiographs],
1984
|
| 90 |
|
DGSF-101 through DGSF-104; MGSF-1 through MGSF-3; MEC-1 through MEC-2; Mind-1 -- experiment documentation,
1984-1985
|
| 91 |
|
DGSF-101 through DGSF-104; MGSF-1 through MGSF-3; MEC-1 through MEC-2; Mind-1 [24 autoradiographs],
1984-1985
|
| 91 |
|
EP, DEP, I-EP, D, IND, PBS -- experiment documentation,
1984-1985
|
| 91 |
|
EP-1 through EP-5, EP-C1; DEP-1-4, 6; I-EP-1 through I-EP-5; D-1 through D-5; IND-1 through IND-5; PBS-5, C2, C3 [100 autoradiographs],
1984-1985
|
| 91 |
|
MBF-1-2, 4-10, 12, 14, 16, 17-21 [mouse blood flow] [39 autoradiographs],
1984-1985
|
| 91 |
|
Woody 1-9, 11-33, 37, 39-40, 44-45, 48, 50, 52, 54, 61, 65-66, 68-77, 79-87 [63 autoradiographs],
1984-1985
|
| 92 |
|
AN-13-15, 17-23 -- experiment documentation,
1985
|
| 92 |
|
AN-13-15, 17-23 [30 autoradiographs],
1985
|
| 92 |
|
EC-1-4, 6-7; G6 PASE [22 autoradiographs],
1985
|
| 92 |
|
G6 PASE-1-3, 5-58; G6 PASE-P1, 2, 4, 6, 7 [70 autoradiographs],
1985
|
| 92 |
|
H-6; HM [6 autoradiographs],
1985
|
| 92 |
|
Leonard -- DG study of 3-month infant with laser lesion of retina -- documentation,
1985
|
| 92 |
|
Papez-9 through Papez-10 [7 autoradiographs],
1985
|
| 92 |
|
Leonard [111 autoradiographs],
1985
|
| 92 |
|
MDGC-1 through MDGC-5; MDGG-1, 3-5; MDGO-2 through MDGO-5 -- experiment documentation,
1985
|
| 92 |
|
MDGC-1 through MDGC-5; MDGG-1, 3-5; MDGO-2 through MDGO-5 [38 autoradiographs],
1985
|
| 92 |
|
MG, MG INS -- experiment documentation,
1985
|
| 93 |
|
MG-001 through MG-002; MG INS-I through MG INS-II [18 autoradiographs],
1985
|
| 93 |
|
Pablo [63 autoradiographs],
1985
|
| 93 |
|
PTX-1 through PTX-9 [25 autoradiographs],
1985
|
| 93 |
|
WDG-1 through WDG-4 [13 autoradiographs],
1985
|
| 93 |
|
WV-1-4, 14 [9 autoradiographs],
1985-1986
|
| 93 |
|
IFNA-1 through IFNA-2; IFNC-1 [interferon] [11 autoradiographs],
1986
|
| 93 |
|
PCP-1, 2, 4, 8-10, 14, 23, 26 [25 autoradiographs],
1986
|
| 93 |
|
PCP-3, 7, 12, 13 [12 autoradiographs],
1986
|
| 93 |
|
PCP-6 and PCP-11 [6 autoradiographs],
1986
|
| 94 |
|
PCP-5, 14-25, 27, 28 [44 autoradiographs],
1986
|
| 94 |
|
PCP-5 -- experiment documentation,
1986
|
| 94 |
|
PT-2-3, 6-18, 20-29, 31-44 [pulse experiments] [39 autoradiographs],
1986
|
| 94 |
|
SA-2-6, 9-12, 14-19 [50 autoradiographs],
1986
|
| 94 |
|
SA-20-23, 25-39 [65 autoradiographs],
1986
|
| 95 |
|
SA-40-46, 48-54, 56-59 [56 autoradiographs],
1986
|
| 95 |
|
SA-60-65, 67-79, 81-83 [72 autoradiographs],
1986
|
| 95 |
|
Sneezy [18 autoradiographs],
1986
|
| 95 |
|
WV-10 through WV-13; WH-2 [10 autoradiographs],
1986
|
| 95 |
|
CJ-1 through CJ-4; Jose-1 through Jose-4 [24 autoradiographs],
1986-1987
|
| 95 |
|
WV-4, 10-12, 14-15; WH-1, 3, 13, 15 -- experiment documentation,
1986-1987
|
| 95 |
|
WV-4, 10-12, 14-15; WH-1, 3, 13, 15 [25 autoradiographs],
1986-1987
|
| 96 |
|
Megan [62 autoradiographs],
1987
|
| 96 |
|
Megan 18, 30, 35, 40, and 48 [5 autoradiographs],
1987
|
| 96 |
|
Sita [46 autoradiographs],
1987
|
| 96 |
|
Sita-10, 13-14, 17, 23, 25-26, 28-29, 32, 34, 38-40, 42-43, 45-46, 55 [19 autoradiographs],
1987
|
| 96 |
|
3H STD, HEX, VH, MG, DG, 3H MG -- experiment documentation,
1987-1988
|
| 96 |
|
3H STD; HEX-1; VH; MG-3; DG; 3H MG [16 autoradiographs],
1987-1988
|
| 96 |
|
CAL [3H calibration] -- experiment documentation,
1987-1989
|
| 96 |
|
CAL [39 autoradiographs],
1987-1989
|
| 97 |
|
Double label experiment -- experiment documentation,
1987-1990
|
| 97 |
|
Double label experiment, [unnumbered] [82 autoradiographs],
1987-1990
|
| 97 |
|
ASP -- experiment documentation (12, 19, 21, 25, 29),
1988
|
| 97 |
|
ASP-12, 19, 21, 25, 29 [5 autoradiographs],
1988
|
| 97 |
|
Bonni-1-7, 9-11, 13-14, 19, 22, 24, 27, 30, 34, 38, 40-42, 45-51, 53-63 [41 autoradiographs],
1988
|
| 97 |
|
Bonni-8, 12, 15-18, 20-21, 23, 25-26, 28-29, 31-33, 35-37, 39, 43-44, 52 [23 autoradiographs],
1988
|
| 97 |
|
FP-3, 5, 6 [14 autoradiographs],
1988
|
| 97 |
|
KGHD-41 -- experiment documentation,
1988
|
| 97 |
|
KGHD-41 [3 autoradiographs],
1988
|
| 97 |
|
LC-6P [3 autoradiographs],
1988
|
| 97 |
|
Leana-1-6, 8-13, 15, 19-21, 25, 28-30, 33-35, 39, 42, 43, 46-49, 51-64 [44 autoradiographs],
1988
|
| 98 |
|
Leana-7, 14, 16-18, 22-24, 26-27, 31-32, 36-38, 40-41, 44-45, 50 [20 autoradiographs],
1988
|
| 98 |
|
Meth-A-1 through Meth-A-2 [7 autoradiographs],
1988
|
| 98 |
|
Pablo -- experiment documentation (18, 30, 36, 42, 50),
1988
|
| 98 |
|
Pablo -18, 30, 36, 42, 50 [5 autoradiographs],
1988
|
| 98 |
|
Stick -- experiment documentation,
1988
|
| 98 |
|
Stick [25 autoradiographs],
1988
|
| 98 |
|
Stick [39 autoradiographs],
1988
|
| 98 |
|
W202 [16 autoradiographs],
1988
|
| 98 |
|
W220 [17 autoradiographs],
1988
|
| 98 |
|
W230 [10 autoradiographs],
1988
|
| 98 |
|
W236 [16 autoradiographs],
1988
|
| 98 |
|
A15 through A24 and B15 through B24 -- experiment documentation,
1988-1991
|
| 98 |
|
A15 through A24 and B15 through B24 [70 autoradiographs],
1988-1991
|
| 99 |
|
AL-1 through AL-2 (with MRI); ALC-1 through ALC-2 (with MRI) [aluminum treated aged rats[ [29 autoradiographs],
1989
|
| 99 |
|
BF-3 [2 autoradiographs],
1989
|
| 99 |
|
C1C6 series [compare decarboxylation of (1-14C) DG and (6-14C) DG] experiment documentation,
1989
|
| 99 |
|
C1C6 series -- A1B1; A-1, 5-14; B-1, 5-11, 13-14 [69 autoradiographs],
1989
|
| 99 |
|
Yoshi 2-1 through Yoshi 2-10 [aluminum treated aged rats] [43 autoradiographs],
1989
|
| 99 |
|
MK-HOR [3 autoradiographs],
1989
|
| 99 |
|
O43 [18 autoradiographs],
1989
|
| 99 |
|
Sally-1-9, 11-12, 14-15, 17-18, 20, 23-24, 26, 28, 31, 34-35, 37, 39, 41-43, 46-52, 54-61 [48 autoradiographs],
1989
|
| 100 |
|
Sally-10, 13, 16, 19, 21-22, 25, 27, 29-30, 32-33, 36, 38, 40, 44-45, 53 -- experiment documentation,
1989
|
| 100 |
|
Sally-10, 13, 16, 19, 21-22, 25, 27, 29-30, 32-33, 36, 38, 40, 44-45, 53 [18 autoradiographs],
1989
|
